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ABSTRACT 
 
INVESTIGATING ESTROGENIC ENDOCRINE DISRUPTING COMPOUNDS AND THEIR 
DISINFECTION BYPRODUCTS WITHIN DRINKING WATER TREATMENT 
 
September 2011 
 
KIRSTEN E. STUDER, B.S., UNIVERSITY OF MARY WASHINGTON, 
B.S.C.E., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor David A. Reckhow 
 
Emerging public health concerns relating to the epigenetic effects of EDCs, along with the 
reconceptualization of dose response curves, provides a compelling rationale for addressing 
estrogenically active contaminants in drinking water.  These environmental health concerns are 
now known to have long lasting impacts, especially on fetal development.  For this drinking 
water research, the estrogenic EDC byproducts were identified and the treatment processes were 
compared using the dose applied, the number of byproducts formed and the relative 
quantification of the treatment byproducts.  The analytical optimized method presented and 
implemented in this research successfully determined the percent degradation of the parent 
compound for each disinfection treatment selected.  From the resulting data, the chlorination of 
EE2 and DES produced the highest percent degradation of the parent compound, with the least 
number of byproducts.  The optimized method decreased sample variability; showed a better fit 
to a linear calibration with both high and low concentrations of the parent compound; and lower 
MQLs and MDLs.  Continuing research is needed to help in understanding the complete 
consequences of estrogenic endocrine disruptors in drinking water and the inevitable public 
health impact.
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CHAPTER 1 Introduction 
1 Introduction 
1.1 Overview of the Endocrine Disruptor Problem 
One group of drinking water contaminants that has been of particular world-wide concern is 
endocrine disrupting chemicals or EDCs.  The present research builds on and extends studies of 
EDCs that demonstrate the potential dangers of low level chemical interactions and by-product 
formation produced by traditional decontamination techniques (Huber et al., 2004; Petrovic et 
al., 2004; Richardson, 2002).  A kinetic model for chemical decontamination processes is, 
therefore, required to determine the behavior and complexity of the chemical system.  This 
includes not only direct chemical analysis but simulation of chemical processes that may have an 
adverse future impact on the water system.  Such kinetic models will provide the foundation for 
rapid response required to rectify compromised water systems, whether this has been caused by 
increased use of biologically active compounds, natural disasters, or other situations.   
 
EDCs are anthropogenic chemicals, which disrupt the endocrine system of animals and humans, 
even when the exposure dosage is low.  The United States Environmental Protection Agency 
(USEPA) defines endocrine disrupting chemicals as “exogenous agents that interfere with the 
synthesis, secretion, transport, binding, action or elimination of natural hormones in the body 
that are responsible for the maintenance of homeostasis, reproduction, development, and/or 
behavior” (EPA, 2010).  The definition that the USEPA provides only allows external sources to 
be designated as EDCs; however, external factors are not the only factors in an organism’s 
environment that can act as EDCs.  In addition to the exogenous sources, the internal hormonal 
system can be altered in a way that can propagate endogenous effects from previous exogenous 
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exposures, with biological pathways being activated and inactivated at inappropriate times; 
therefore, disrupting the endocrine system (Birnbaum and Fenton, 2003).  Such second-order 
effects can initiate long term systemic disruptions. 
 
The endocrine system is critical because it works in parallel with the nervous system to direct 
growth and maturation (Thomas et al., 1992).  It is also important because it manages, regulates, 
and coordinates a constant internal environment, through homeostasis, by sending chemical 
messages to the appropriate receptor cells.  Estrogens are one type of chemical messengers, or 
hormones that promote and maintain the development of the female secondary sex characteristics 
within the endocrine system (Farabee, 2001).  Because the endocrine system is a delicate balance 
of complex chemical pathways, it is not always apparent from observing the outcomes that the 
overall effect is proportional to the level of disruption. 
 
According to Gilbert and Epel, endocrine disruption is a functional change to tissue that appears 
superficially normal (2009).  The pathology may be evident only in minute inspection and/or it 
may manifest solely as an alteration in gene expression.  The sensitivity to endocrine disruption 
depends on the developmental stage, dose of the endocrine disruptor, and sex of the exposed 
entity.  With the addition of a disruptor, there may be an additive or synergistic effect with 
nutritional and genetic background influences.  The relative effect of endocrine disruption can 
span generations due to morphogenesis leading to dysfunctional physiology, which can be 
transmitted to the next generation (Gilbert and Epel, 2009; Norris and Carr, 2006). 
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1.2 Exposure to Endocrine Disruptors 
Endocrine disruptors are introduced to the environment through many venues, as discussed in 
Section 1.6.1 Source of EDCs in the Environment.  Once these contaminants are in the 
environment, they are difficult to detect and often impossible to avoid.  Since endocrine 
disruptors are active at very low levels, the amounts found in the environment are often deemed 
harmless yet have potential implications to the functioning of the body’s endocrine system.   
 
The endocrine system is very complex and has many pathways that can be disrupted internally 
(endogenously) and externally (exogenously).  Complex systems are characterized by such 
interactions that lead to the emergence of new relationships at different levels of chemical 
organization.  The endocrine system, as a complex system, is composed of ductless glands that 
secret various hormones into the vascular system which are then transported to distant target 
tissues, where the hormones produce specific effects (Norris and Carr, 2006).  Chemical 
regulators are also released into the vascular system by the nervous system (neurohormones) to 
regulate the release of hormones.  This activity typically takes place within the liver, heart, 
kidneys and adipose tissue (Brown, 1994). 
 
Endocrine disruptors can also interrupt other pathways in the body and are not limited to the 
endocrine system.  The signals between cells, within cells, between organs and between 
organisms are all vulnerable to endogenous and exogenous disruption (Colburn, 1997). 
 
Human exposure to these chemicals in food, water and the environment is a growing critical 
concern with unknown long-term and multi-generational impacts.  Humans have evolved 
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chemical defenses that help protect against some natural and synthetic endocrine disruptors; 
however, natural compounds are more likely to be eliminated by the biological defense system 
(Colborn, 1997).  Synthetic EDCs are more likely to be overlooked by the body’s defense 
mechanisms because they mimic the natural compounds activity in the normal biological 
pathways.   
 
Some EDCs have been linked to birth defects, infertility, immune system suppression, 
deformities to the reproductive organs, and various other health problems (McLachlan, 2001).  
Exposure to EDCs, such as estrogenic EDCs, has been implicated in the observed decrease in 
sperm counts in human males (McLachlan et al., 1996; Miljoproekt, 1995).  More significantly, 
the developing fetus is exceptionally sensitive to both the natural hormone signals used to guide 
its development, and the exogenous chemical signals that reach it from the environment.  These 
natural signals and exogenous "morphogens" guide the fetus through its developmental path and 
help set the sensitivity to subsequent hormonal signals. This involvement of setting sensitivity 
can have life-long and multi-generational consequences.  
 
Some of the synthetic chemical compounds are even more worrisome due to their accumulation 
in fatty tissues within the body (Langston, 2010).  These EDCs can be passed on in the womb 
and through breast milk to infants at critical stages in their growth cycles.  The chemical 
accumulation in the fat tissue and breast milk can reach very high concentrations over time, 
based on exposure type.  In humans, the metabolic half-lives of estrogenic EDCs estradiol and 
ethinylestradiol are approximately 20 min and 17 h, respectively (Bolt et al., 1996).  Even 
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though these half-lives are relatively short, there may be long term effects associated with such 
exposures. 
 
Early developmental stages through puberty are especially vulnerable to chemical exposure due 
to the rapid changes that occur during this time, which are dramatically enhanced compared with 
that in an adult.  A fetus changes quickly, with rapid cycles of cell division and growth, and 
massive changes in the patterns of gene activation over time.  Exposure to EDCs can initiate a 
process of “flipping switches” on and off (DNA methylation) at inappropriate times during 
sexual development, which can lead to transgenerational epigenetic effects.  With these 
numerous changes, there is ample opportunity for disruption leading to mistakes in 
developmental transcription.  Comparable periods of cell division, differentiation and growth do 
not occur during adulthood; therefore, the opportunity for disruption of the pathways is 
substantially less compared to the prenatal through puberty period.  
 
Another reason for the susceptibility toward disruption in fetal systems stems from the 
incomplete development of the blood-brain barrier when still in the womb (Gilbert and Epel, 
2009).  A second physiological barrier that is incomplete in fetuses is the enzymatic mechanisms 
that help to eliminate contaminants (Birnbaum et al., 2003).  Therefore, fetal effects from 
maternal exposure at critical stages of development can have adverse effects on the fetus and 
subsequent generations but not have any effect on the mother.  Figure 1-1 shows the specific 
sensitivities of an embryo/fetus to "morphogens," referred to as terotogens. 
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Figure 1-1: Developmental Sensitivity to Teratogens (Moore and Persaud, 1993) 
 
Experimental evidence from animals shows that exposure to endocrine-disrupting compounds in 
early development can cause cancer and/or increase vulnerability to cancer-causing agents later 
in life (Birnbaum et al., 2003).  Almost all human epidemiological research into cancer risk from 
contaminant exposures examines contaminant levels at the time of diagnosis or afterward; 
therefore, the assessment fails to include an entire period of developmental sensitivity to 
exposures that animal studies have identified.  The critical exposure window may be much 
earlier than when the current dose response measurement is made if the early stages of life are 
critical to disease susceptibility. 
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Many of the exposure effects may not be recognizable or quantifiable until many generations 
later.  Epigenetic impacts from exposure to EDCs are a very real consequence for their presence 
in the environment.  Some responses already point to these contaminants as the reason for 
decreased sperm counts and increased cases of breast cancer (Melmed et al., 2008; vom Saal et 
al., 1995).   
 
Another issue is the synergistic effects stemming from exposure to multiple contaminants.  
Research has shown that the hormonal activity in a mixture of EDCs is higher than the individual 
levels of each contaminant added together (Gilbert and Epel, 2009).  Since there are no one-
contaminant exposures to humans and other organisms, the synergetic effects are very relevant.  
Since the mechanisms of disruption are diverse and complex, a compound may be an agonist 
(mimicking the actions of a hormone) or antagonist (interfering or blocking actions of a 
hormone); it may alter transport of a hormone; or it may bind to more than one hormone receptor 
(Brown, 1994). 
 
1.3 Endocrine Disruptors Dose Response 
The effects on human and animal health may be even more difficult to assess due to the 
complexity of the endocrine system.  The dose-responses appear to depend on the chemical 
structure and dose of the individual compound, the duration of the exposure, and the species, 
developmental stage (age) and gender of the organism (Metzler and Pfeiffer, 2001). 
 
There are many reasons why it is not yet clear as to whether these contaminants are harmful.  
This is mainly because not all subgroups within a population react to the exposure in the same 
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manner and the exposure effects may not be revealed until several generations.  Because of the 
discrepancies in views and conclusions within current literature, there is no consensus suitable 
for the development of policy guidelines governing the presence of EDCs in the environment.  
Whether a decision is made to remove them from the water supply or treat for their presence is 
an ongoing debate in the drinking water community. 
 
When pharmaceuticals and other drinking water contaminants are tested for exposure limits in a 
population, tests are typically conducted using healthy adults as a baseline guide.  The estrogenic 
compounds and other hormonal steroids, however, have a greater disruption effect in a fetus and 
pubescent adolescences than mature adults.  Numerous studies have shown that exposure to 
EDCs during critical periods of differentiation, at low environmentally relevant doses, can alter 
development programming resulting in obesity, diabetes and other adverse health effects. 
(Newbold, 2008; Baille-Hamilton, 2002).  A new term, “environmental obesogens,” has been 
created to describe these estrogenic contaminants and their adverse health effects (Grün and 
Blumberg, 2009). 
 
When the endocrine system is subjected to a therapeutic, chronic dose of steroidal estrogens, it 
may produce decreased glucose tolerance, changes in menstrual cycle and breast changes (NLM, 
2003).  In men exposed to estrogens consistently, prolactinoma occurs, which is a growth of a 
noncancerous pituitary tumor that produces a hormone called prolactin.  Prolaction is a hormone 
that triggers the breasts to produce milk, or lactate (Melmed et al., 2008).  
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There is an increasing concern about the complexity in the biology of dose response curves.  The 
traditional view holds that the effect is proportional to the cause.  With this assumption, a dose 
response curve is either linear or monotonic.  A linear dose response curve is produced when the 
dose and response have a direct relationship; thus, when the dose is increased the response is 
increased.  A monotonic dose response curve shows that the direction of change does not reverse 
but there is no constant proportional relationship.  In other words, nonlinearity says that the 
effect is not consistently proportional to the cause; rather it is an interacting “domino effect” 
(Masters, 1997).  The monotonic curves can be described in mathematical terms to represent the 
response to each dose. 
 
Non-monotonic dose response curves do not demonstrate a direct relationship between dose and 
response.  In non-monotonic dose response curves, the shape of the curve reverses as the level of 
contamination increases. Simulation rather than mathematics is needed to determine a dose 
response for a contaminant that follows a non-monotonic curve.  A non-monotonic curve is often 
referred to as a “U-curve,” with high responses at low and at high levels of contamination.  
Inverted “U-curves” are also non-monotonic, but have the greatest response in intermediate 
ranges of contamination.  The non-monotonic curves are also referred to as hermetic dose 
response curves (Baldi and Bucherelli, 2005; Calabrese, 2009; Mattson, 2008).  Figure 1-2 
shows pictorial descriptions of various dose response curves. 
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A. Linear Curve        B. Monotonic Curve 
 
   
C. Non-Monotonic Curve   D. Non-Monotonic Curve 
Figure 1-2: Dose Response Curves (adapted from Colburn, 1997) 
 
Estradiol has been found in multiple dose response studies to follow a strong non-monotonic 
curve over a wide range of exposures (Christian and Gillies, 1999; Welshons et al., 2003).  
Welshons et al. concludes that within the range of concentrations of estradiol typically found in 
the environment (parts per quadrillion to parts per trillion), responses to estradiol are mediated 
by the estrogen receptor.  At higher levels, those in the range normally used in toxicological 
experiments, the impact of estradiol is not receptor mediated.  Figure 1-3 is a dose response 
curve for estradiol, the most common endogenous estrogenic compound. 
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Figure 1-3:  Estradiol Dose Response Curve (Welshons et al., 2003) 
 
Another classic example of non-monotonic dose-response curves comes from a study by vom 
Saal et al. examining the effect of the synthetic estrogen diethylstilbestrol (DES) on pregnant 
mice and their offspring (vom Saal et al., 1997).  This study measured the prostate weight in the 
male offspring of pregnant mice given a single dose in the range of 0 to 200 ng DES/g body 
weight.  Figure 1-4 is a graph of the results of DES dose versus prostate weight. 
 
 
Figure 1-4:  Dose Response of Pregnant Mice Given DES and Measured 
Response of Offspring Prostate Weight (vom Saal et al., 1997) 
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According to vom Saal et al., this type of inverted U function is typical of studies of the effects 
of estrogen on development.  Due to both vom Saal and Welshons research findings, it must be 
considered that permanent alteration in the functioning of estrogen-responsive organs in animals 
and humans could occur due to exposure during fetal life.  This exposure could be a result of low 
doses of estrogenic chemicals present in drugs (i.e. birth control pills) or from environmentally 
relevant concentrations of estrogenic chemicals present in food, water, and air (vom Saal, 1997). 
 
The non-monotonic curves for EDCs could and should change the calculation to determine the 
no observed adverse effect level (NOAEL) and the lowest observed adverse effect level 
(LOAEL) (Calabrese, 2009; DeSimone, 2009).  Because of the non-monotonic dose response 
curves it is important not to rest on extrapolating high dose curves down to the low end of EDC 
exposure.   
 
1.4 Steroidal Endocrine Disruptors 
In the endocrine system, there are two major receptor molecules, ERα and ERβ, for the steroidal 
estrogenic hormones.  The binding ligands are activated by 17β-estradiol or other estrogenic 
compounds that can dimerize and bind to the regulatory regions of estrogen-sensitive genes 
(Nelson and Cox, 2004).  When the receptors bind with endogenous or exogenous estrogens, it 
activates a “signaling cascade” of cellular actions or binds to a DNA sequence (estrogen-
responsive elements) and controls the transcription of the genes (Gilbert and Epel, 2009). 
Figure 1-5 shows the five estrogenic EDCs that are discussed in this research; including three 
natural estrogens (E1, E2 and E3) and two synthetic estrogens (EE2 and DES).  The five EDCs 
are steroidal hormones, which are in the lipids class. 
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Figure 1-5:  Estrogenic Endocrine Disruptors 
 
Relative estrogenic strength of the five estrogens is as follows from highest to lowest biological 
activity: DES > EE2 >>E2 > E1> E3.  The relative strengths are based on the source of the 
estrogenic compound (endogenous versus exogenous), the origin of the compound (natural 
versus synthetic), the abundance of the compound in the body naturally and the activity of the 
estrogen (McLachlan and Arnold, 1996).  By considering the relative strengths, an estrogen 
equivalent factor effect can be found relative to estradiol or various bioassay responses 
(Campbell et al., 2006).  
 
The estrogenic drugs, such as ethinylestradiol, found in birth control pills are more stable and 
remain in the body longer than natural estrogens, like estradiol.  Natural hormones are short-
lived, do not accumulate in tissue and are easily degraded by our bodies.  Most natural estrogens 
stay in the bloodstream only minutes or at most a few hours (Tait et al., 1991).  After that, 
14 
 
enzymes in the liver degraded the hormones into smaller compounds. These components are 
either flushed out as a waste product or reused to build other molecules.   
 
In contrast to natural estrogens, estrogenic drugs and synthetic environmental estrogens are not 
easily or readily degraded; are long-lived, remaining intact in the environment and in living 
organisms for many years; and can accumulate in the natural world and within the fat and tissue 
of animals and humans.  However, they are not nearly as persistent as pesticides and other 
environmental estrogens.  Upon exposure, some of these estrogenic chemicals can be either 
flushed out or a portion can be absorbed into the body where they can bioaccumulate in fat and 
muscle (Cameron et al., 1993; Mendel et al., 1989; Miljoprojekt, 1995; Thomas et al., 1992).  
Because most are lipophilic, they tend to accumulate in fatty tissue and stay there for years.  
During stress, such as pregnancy or breast feeding, these substances can be released from fat and 
redistributed or passed on to offspring.  There is no doubt that humans are all exposed to some 
environmental estrogens.  Whether or not the accumulated amounts are enough to produce long-
term health problems is unknown.  
 
Once steroid hormones are inside the body, they are metabolized primarily by conjunction with 
groups that interfere with interaction of the steroid to its binding proteins or receptors and render 
them more soluble in blood plasma (Norris and Carr, 2006).  The majority of metabolism occurs 
in the liver; thus, the steroid hormones can then be readily excreted in sweat, urine and feces. 
 
The biological pathway which produces the natural estrogens begins with cholesterol and is 
referred to as steroidogenesis.   
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Figure 1-6 shows the pathways from cholesterol to the production of the natural hormones 
including the estrogenic hormones; estrone, estradiol and estriol.   
 
 
Figure 1-6:  Steroidogenesis (Boron et al., 2003) 
 
The development of secondary sex characteristics in women is driven by estrogens, to be 
specific, estradiol.  Estradiol, like other steroids, is derived from cholesterol. After side chain 
cleavage and utilizing the delta-5 pathway or the delta-4 pathway, androstenedione is the key 
intermediary. A small amount of the androstenedione is converted to testosterone, which then 
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undergoes conversion to estradiol by an enzyme called aromatase. In an alternative pathway, 
androstenedione is "aromatized" to estrone, which is subsequently converted to estradiol (Gilbert 
and Epel, 2009).  Based on the steroidogensis diagram above, it is clear that these pathways are 
extremely important for normal body function and that there are multiple reactions that can be 
disrupted and/or magnified with “outside” contaminants, such as estrogenic environmental 
contaminants. 
 
1.5 Environmental Estrogens  
Both natural and synthetic estrogens have been detected in the environment.  Even at the low 
levels found in the environment, these estrogens are still classified as endocrine disrupters due to 
their biological activity that is present at low concentrations.  This research focuses on three 
natural estrogens (estrone, estradiol and estriol) and two synthetic estrogens (ethinylestradiol and 
diethylstilbestrol).  The main emphasis is devoted to the synthetic estrogens due to their 
magnitude of biological activity, their longevity and their stability in comparison to the natural 
estrogens. 
 
1.5.1 Estrone 
Estrone (E1) is a naturally occurring estrogen that is produced in the ovaries and the adrenal 
glands.  The chemical formula for estrone, shown in Figure 1-7, is a ketone C18H22O2 (MW 
270.37 g/mole).  The solubility of estrone in water is 4.6 mg/L or 17 µM.  The pKa of the 
phenolic moiety in E1 is 10.34 (Huwitz and Liu, 1977). 
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The IUPAC name, or International Union of Pure and Applied Chemistry nomenclature, for E1 
is 3-hydroxy-13-methyl- 6,7,8,9,11,12,13,14,15,16- decahydrocyclopenta[a]phenanthren- 17- 
one. 
 
HO
O
 
Figure 1-7:  Estrone (E1) 
 
In prepubescent children, men and postmenopausal women, a major quantity of estrone is 
derived from secondary tissue conversion of androstenedione, a steroid hormone.  Estrone is a 
primary estrogenic component of several pharmaceutical formulations, including those 
containing conjugated and esterified estrogens (Petrovic et al., 2004).  Because of the extensive 
use of E1 in the treatment of estrogen deficiency and the incomplete metabolism by the users, 
significant concentrations have been observed in wastewater.   
 
This endocrine disrupter is part of an emerging group of contaminants that have been noted for 
their presence in surface water (Thomas and Colburn, 1992).  Some EDCs, similar to E1, have 
been linked to birth defects, infertility, immune system suppression, deformities to the 
reproductive organs, and various other health problems (Thomas and Colburn, 1992). 
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Estrone is the least abundant of the three natural hormones; estrone, estradiol and estriol. E1 is 
relevant to health and disease states because of its conversion to estrone sulfate, a long-lived 
derivative, which acts as a reservoir that can be converted as needed to the more active estradiol.  
Estrone sulfate is commonly found in wastewater, primarily from urine. 
 
1.5.2 Estradiol 
Estradiol (E2) is an endogenous, natural estrogen that is produced from a conversion of estrone 
to estradiol metabolized through the liver and excreted from the body through urine (Gore, 
2007).  This natural estrogen is the predominant sex hormone found in females and is typically 
assumed as the structure of estrogen; however, it is one of a group of estrogens.  Within the 
female body, this hormone is responsible for changes in the body shape; affecting bones, joints 
and fat deposition.  Estradiol is present almost always in the reproductive female body.  Estradiol 
is also present in males but at much lower levels. E2 has a chemical formula of C18H24O2 (MW 
272.38 g/mole) with a chemical structure shown in Figure 1-8.   
 
The IUPAC name for estradiol is (17β or 17α)-estra-1,3,5(10)-triene-3,17-diol.  There are two 
forms of estradiol 17α and 17β, referring to the position of the hydroxyl group on C17.  For the 
purposes of this research, the term estradiol will refer to 17β-estradiol, which is more commonly 
found in surface waters and drinking waters. 
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Figure 1-8:  17β-Estradiol (E2) 
 
Like estrone, estradiol is almost insoluble in water, with a solubility limit of 3.600 mg/L (13.22 
µM) at 27ºC (Yalkowsky, 1987).  The pKa of phenolic moiety is 10.46 (Huwitz and Liu, 1977). 
 
Estradiol is the most biologically active naturally-occurring estrogen.  In addition to occurring 
naturally in the body, estradiol is also an active ingredient in many medications for birth control, 
hormone replacement therapy, infertility treatments and vaginal infections.  These medications 
are delivered to the body through a variety of methods, including oral ingestion, trans-dermal 
application, injections and ointments.  There are numerous adverse effects that are associated 
with an imbalance of estradiol.  These effects range from minor health problems such as nausea, 
migraines and dizziness to major health problems such as breast cancer, strokes and heart 
attacks.  E2 has also been linked to birth defects and deformities to the reproductive organs.  A 
derivative form of estradiol is EE2. 
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1.5.3 Estriol 
Estriol (E3) is also a natural estrogen like estrone and estradiol. Figure 1-9 shows the chemical 
structure of estriol, which has a formula of C18H24O3 and a molecular weight of 288.38 g/mole.  
The pKa of the phenolic moiety in estriol is 10.38 (Huwitz and Liu, 1977).  According to 
Campbell et al., the solubility of estriol is 32 mg/L in water, which is significantly higher than 
the other steroidal estrogens (2006). 
 
Estriol’s IUPAC name is (8R,9S,13S,14S,16R,17R)-13-methyl-7,8,9,11,12,13,14,15,16,17-
decahydro-6H-cyclopenta[a]phenanthrene-3,16,17-triol. 
 
HO
OH
OH
 
Figure 1-9:  Estriol (E3) 
 
Estriol is abundant primarily during pregnancy and is a common metabolite of estrone and 
estradiol in animals and humans.  E3 is excreted in humans as conjugated and unconjugated 2-
hydroxy estriol after hydroxylation (IARC, 1979).  There is limited evidence in experimental 
animals for the carcinogenicity of estriol (IARC, 1999). 
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Research has shown that estriol in the presence of estradiol will act as an antiestrogen, therefore, 
reducing the activity of estradiol (Melamed, 1997).  This research suggests that estriol assumes a 
protective role in opposing carcinogenic effects of estradiol. 
 
1.5.4 Ethinylestradiol 
Ethinylestradiol (EE2) is an exogenous, synthetic, steroidal estrogen which is commonly used as 
the active ingredient in birth control medications.  EE2 has an IUPAC name of 19-Nor-17α-
pregna-1,3,5(10)-trien-20-yne-3,17-diol and is synthesized from estrone.  Figure 1-10 shows the 
chemical structure of EE2, which is the same as estradiol except for the presence of the 17α-
ethinyl group.  The ethinyl substitution at the C17 position inhibits first-pass metabolism 
(absorption in the gut wall) of EE2, thereby decreasing the metabolism of the drug and 
increasing the biological half-life (INCHEM, 2005).   
 
HO
OH
 
Figure 1-10:  17α-Ethinylestradiol (EE2) 
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The chemical formula for EE2 is C20H24O2 with a molecular weight of 296.41 g/mol.  EE2 is 
almost insoluble in water with a solubility of 4.8 mg/L (Campbell et al., 2006).  The pKa of EE2 
phenolic moiety is 10.40 (Lee et al., 2005). 
 
EE2 is a major component of hormonal contraceptive devices. Combined forms of hormonal 
contraception contain EE2 and a progestin, which both contribute to the inhibition of 
Gonadotropin-releasing hormone (GnRH), Luteinizing-hormone (LH), and Follicle-stimulating 
hormone (FSH). These hormones are released by the pituitary and are involved in reproduction.  
The inhibition of these hormones accounts for the ability of these birth control methods to 
prevent ovulation and thus prevent pregnancy (Gore, 2007). 
 
Like other steroidal hormones, EE2 is thought to act primarily through the regulation of gene 
expression. As a lipophilic hormone, it diffuses readily through cellular membranes to bind to 
estrogen receptors situated in the nucleus.  The receptor interacts with a specialized nucleotide 
sequence, resulting in either an increase or decrease in the transcription of hormone regulated 
genes (INCHEM, 1997). 
 
1.5.5 Diethylstilbestrol 
Diethylstilbestrol (DES) is a synthetic non-steroidal estrogen (teratogen) which was used in 
growth hormone in the meat industry (1960s) and in birth control (1970s).  Figure 1-11 shows 
the structure of DES, with two phenol groups connected by 4,4'-(3E)-hex-3-ene at C3 and C4.  
The IUPAC name for DES is 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol. 
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Figure 1-11:  Diethylstilbestrol (DES) 
 
Molecular weight of diethylstilbestrol is 268.35 g/mol with a chemical formula of C18H20O2. 
The solubility of DES in water is 0.0956 mg/L at 25 ºC, which is almost insoluble (Syracuse 
Research Corporation, 1988).  The pKa of the phenolic moieties in DES are 9.55 and 10.19 (Box 
et al., 2009). 
 
Diethylstilbestrol was the earliest synthetic form of the hormone estrogen.  It was once widely 
prescribed to prevent miscarriages and premature births in the 1950s and 1960s. DES is still 
available for prescription in the US to treat breast cancer and prostatic cancer.  Both treatment 
uses of DES are for only select patients with metastatic or advanced disease (MedTerms™ 
Medical Dictionary, 2002).  DES is also currently used in canine and feline veterinary medicine 
for treatment of urinary incontinence, prevention of pregnancy, treatment of prostatic 
hypertrophy and treatment of tumors (Forney, 2004). 
 
The side effects of DES are quite drastic.  According to the CDC, DES usage is linked to vaginal 
cancer (clear cell adenocarcinoma, CCA) in the daughters (DES Daughters) resulting from a 
pregnancy that was prescribed DES; women prescribed DES while pregnant have increased risk 
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of breast cancer; and there is an increased risk for non-cancerous epididymal cysts in the sons 
(DES Sons) resulting from a pregnancy for a woman that was prescribed DES (2003). 
 
Table 1-1 summarizes the characteristics of the environmental estrogens discussed in the 
previous sections. 
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Table 1-1: Summary of the Properties Associated with each Estrogenic Compound 
Estrogen Abbreviation Origin Chemical Formula 
Molecular 
Weight (g/mol) 
Differing Functional 
Group 
Solubility in 
Water 
pKa (s) 
of Phenolic Moiety  
Estrone E1 Endogenous C18H22O2 270.37 
R
R
O
 
Ketone on C17 
4.6 mg/L  
(17 µM) 10.34 
Estradiol E2 Endogenous C18H24O2 272.38 
R
R
OH
 
Hydroxyl group on C17 
3.6 mg/L  
(13.2 µM) 10.46 
Estriol E3 Endogenous C18H24O3  288.38 
R
R
OH
OH
 
Hydroxyl groups on 
C16 and C17 
32 mg/L 
(110 µM) 10.38 
Ethinylestradiol EE2 Exogenous C20H24O2 296.41 R
R
OH
 
Hydroxyl group on C17 
and Ethinyl group on 
C16 
4.8 mg/L 
(16 µM) 10.40 
Diethylstilbestrol DES Exogenous C18H20O2 268.35 
R
OH
 
Additional Phenolic 
group 
0.096 mg/L 
(0.36 µM) 9.55 and 10.19 
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1.6 EDC Drinking Water Contamination 
The following sections address the multiple sources that can contribute to contamination, the fate 
of the contaminants and the implications for these environmental contaminants in the drinking 
water supply. 
 
1.6.1 Source of EDCs in the Environment 
There is increasing concern that wastewater effluent discharge streams located in close proximity 
to drinking water intakes may compromise drinking water supplies.  The resulting increased 
contaminant loads may place a heavy burden on drinking water utilities (van der Linden, 2008).   
 
There are many pathways for contaminants to enter the drinking water supply, by natural and/or 
anthropogenic means.  Contamination of water supplies can be either from point or non-point 
sources.  The estrogens studied in this project are both synthetic and natural, which suggests 
multiple sources for contamination.   
 
Since many emerging contaminants are found in discharge streams from wastewater treatment 
plants, there is an increasing need to monitor and evaluate the distance between the waste stream 
and the drinking water source associated with surface waters.  Many of these emerging 
contaminants have not been measured for surface waters in the United States because the 
analytical technology needed to detect trace levels is quite costly.  Now that there is technology 
available to measure at trace levels with decreased cost, new strategies are needed to help 
monitor the quality of our source waters used for municipal drinking water.  If improved 
strategies are set in place to identify impaired areas, then water monitoring samples will only be 
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needed in select places, thereby, decreasing the number of samples needed to monitor a 
watershed. 
 
A major concern within the emerging contaminant groups has been the pharmaceuticals and 
personal care products (PPCPs) that have entered the environment.  Many of these compounds 
have been found in selected areas around the county, with most detections stemming from 
wastewater discharge (Servos, 2005).  Since many wastewater treatment plants discharge directly 
in surface waters that are upstream of drinking water intakes, it is very important to understand 
the persistence of PPCPs in the aquatic environment. 
 
Estrogenic EDCs can be introduced to the environment from wastewater, pharmaceutical 
industries, hospitals and animal farming (confined animal feeding operations or CAFOs), etc. 
One of the main sources of the natural water pollution by EDCs is sewage-treatment plants 
(STP). It has been reported that, because of partial removal or formation of an active form during 
the process of sewage treatment, endocrine disrupters are released in surface waters or adsorbed 
onto sewage sludges (Gomez et al., 2006; Ternes et al., 1991).  Drinking water is also 
contaminated by these chemicals and their breakdown products found in industrial discharge as 
well as sewage effluent.  Figure 1-12 shows a schematic of several sources and sinks associated 
with EDCs. 
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Figure 1-12:  Fate of EDCs in the Environment (Campbell et al., 2006) 
 
The main source of estrogens in municipal wastewater is urine, which contains 67-80% of 
estrogens excreted daily (Maurer et al., 2006).  The mean of the per capita loading for influent 
concentrations that were determined for the model are as follows: 3.3 µg of E2/person/d, 13.8 µg 
of E1/person/d, 0.89 µg of EE2/person/d.  These concentrations were found by dividing the flow 
by influent concentrations by the average excretion of the respective estrogens (Johnson et al., 
2004). 
 
The occurrence level of EDCs in drinking water primarily depends on the level of wastewater 
contamination within a watershed (AwwaRF, 2008).  Because varying levels of EDCs are 
used/disposed within watersheds, the total amount of biologically active contaminants introduced 
to the environment has a wide range depending on the removal rates of the wastewater treatment 
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systems.  According to an AwwaRF publication on the occurrence on EDCs, steroid hormones 
have a detection frequency in wastewater effluents of over 60 % in both North America and 
Europe, with median concentrations of >12 ng/L (2008).  Even if the removal efficiency of 
steroidal EDCs in wastewater treatment is 90% (Snyder et al., 2003), then 1.2 ng/L of the steroid 
hormones remains in the effluent.  Assuming a dilution ratio of wastewater effluent to surface 
waters of 1:1000, the absence of degradation between treatment plants and a drinking water 
treatment removal efficiency of 90% (Snyder et al., 2003), then 0.12 pg/L of the steroid 
hormones may be introduced into the drinking water distribution system. 
 
Figure 1-13 shows the percent EE2 metabolized and excreted by a female taking birth control 
where the active ingredient is EE2. 
 
 
Figure 1-13:  Excretion of Ethinylestradiol in the Body (adapted from Johnson et al., 2004) 
 
The conjugates of estrogenic EDCs found in wastewater have been shown to come from urine.  
These conjugates will deconjugate within the collection systems and the treatment plants.  The 
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organic loading has been suggested as the key parameter for degradation of estrogens due to the 
potential for competitive substrate inhibition limiting biodegradation.  The removal efficiencies 
for steroid estrogens in wastewater treated with nitrification/denitrification processes are greater 
than 90 %; however, there is a small amount of EDCs remaining in the treatment plant effluent 
which is then released back to the environment (Koh et al., 2009). 
 
Synthetic estrogens can also be introduced to wastewater when unused birth control pills and 
other pharmaceuticals are flushed for disposal.  After synthesis, DES can be introduced to the 
environment during transport, storage or disposal. If released to soil, diethylstilbestrol is 
predicted to strongly adsorb to the soil.  If released to water, diethylstilbestrol may 
bioconcentrate in aquatic organisms and strongly adsorb to suspended solids (Spectrum 
Laboratories, 2003). 
 
There are numerous surface waters that could be categorized as compromised because of water 
reuse, or source waters containing a substantial percentage of wastewater effluent.  Even with the 
ability of current technology to detect contaminants, the process is very labor intensive and very 
expensive.  There are many discharges, other than sewage, that can release low levels of PPCPs 
into the environment.  Once the water system is compromised by decreased source quality, the 
costs to produce high quality water rapidly escalate. 
 
The water intake and wastewater discharge data can be obtained from the EPA’s list of National 
Pollutant Discharge Elimination System (NPDES) permits for Massachusetts.  The permit 
provides two levels of control with technology-based limits and water quality-based limits.  The 
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technology-based limits determine if there is sufficient analytical ability to provide protection of 
the water body.  The second level of the NPDES permits, water quality limits, is based on the 
ability of dischargers in the same industrial Office of Wastewater Management-Water Permitting 
category to treat wastewater (EPA, 2008).  The NPDES Database for the Commonwealth of 
Massachusetts is available through the EPA; however, the current permits do not include PPCPs 
or biologically active compounds.   
 
Figure 1-14 and Figure 1-15 show the drinking water intake sites and the NPDES Permit sites for 
the Commonwealth of Massachusetts, respectively.   
 
 
Figure 1-14:  Massachusetts Drinking Water Intake Sites 
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Figure 1-15:  Massachusetts NPDES Permit Sites 
 
Proximity to potential sources of steroidal estrogen contamination can create “High Priority 
Sampling Zones” which would direct researchers to high risk drinking water sources.  Sites can 
then be either eliminated or included in frequent monitoring for estrogenic contamination. 
 
There are mounting problems with monitoring and managing these forms of environmental 
pollution.  Environmental management of estrogenic EDCs will rely on source reduction, 
limiting exposure to vulnerable populations, and treatment and remediation of waste streams or 
contaminated sites.  Large scale monitoring networks are needed to accurately understand and 
model the transport mechanisms of these contaminants.   
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The United States Geological Survey (USGS) has implemented the National Water Quality 
Assessment Program, which has been monitoring estrogenic compounds in wastewaters, 
groundwaters and surface waters for the last decade (Barnes et al., 2002; Berdanier and Clay, 
2011; DeSimone, 2009).  Even with these USGS studies, more research needs to be started on 
eliminating or inhibiting the contaminant sources to help mitigate the increasing levels of EDCs 
being found in raw drinking water.  
 
1.6.2 Fate of EDCs in the Environment 
Once endocrine disruptors are introduced to the environment many possible scenarios can occur.  
The EDCs can remain in the vicinity of the initial discharge or they can be transported down-
gradient.  When EDCs are discharged to soils, the compounds can either be adsorbed to the soil 
particles or volatilized into the atmosphere or transported in the dissolved state by percolation, 
groundwater flow or overland runoff.  Degradation could occur depending on the chemical 
components of the contaminant and the chemical surroundings.  Since the volatization rates are 
low for most estrogenic EDCs and their atmospheric half lives are on the order of minutes, 
exposure to these compounds is only significant for those who handle them daily or if a large 
contamination occurs (SRC, 1988).   
 
If the contaminants are transported or introduced into a water source, either ground or surface 
waters, then significant EDC contaminant exposure to the general population is most likely 
through drinking water.  Even though the solubility (Table 1-1) of the estrogenic EDCs is 
relatively low, the concentrations found in the environment are within the physiological response 
level to the low dose, as discussed in Section 1.3 Endocrine Disruptors Dose Response.  
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The extent of estrogenic EDC biodegradation in soils and natural waters is not known, although 
the synthetic estrogens have been shown to be resistant to degradation in activated sludge 
(Gomes et al., 2009).  Based on the influent and effluent concentrations in the study done by 
Johnson et al., there are no relationships that can be attributed to removal by specific steps within 
activated sludge treatment (2004).  If released to surface or ground waters, synthetic estrogens 
and natural estrogens can bioconcentrate in aquatic organisms and strongly adsorb to suspend 
solids and sediments (Langston, 2010). 
 
There have been multiple studies that have found these estrogenic contaminants in drinking 
water (Barnes et al., 2002; Kolpin et al., 2002; Lévi et al., 2002; Vethaak et al., 2002).  With the 
increase in analytical detection potential, more and more surface and ground waters will prove to 
be contaminated with EDCs.  The levels of detection are usually measured in parts per trillion 
(ppt) or parts per quadrillion (ppq).  Table 1-1 presents the mean contamination levels in 
wastewater, surface water and drinking water for estrogenic compounds. 
 
Table 1-2: Mean Levels of Estrogenic Contamination 
EDC Contaminant Levels in Wastewater Influent 
Levels in Surface 
Water 
Levels in Drinking 
Water 
Estrone 20-30 ng/L* 0.1-4 ng/L# 0.2-0.6 ng/L# 
Estradiol 10-15 ng/L* 0.15-3.6 ng/L# 0.2-2.1 ng/L# 
Estriol 60-80 ng/L* 1.0-2.5 ng/L1 0.03 ng/L3 
Ethinylestradiol 1-5 ng/L^ 0.1-5.1 ng/L# 0.15-0.50 ng/L# 
Diethylstilbestrol 4.8–12.4 ng/L4 2 ng/L2 0.11-0.26 ng/L+ 
*Hashimoto et al., 2007; ^ Joss et al., 2004; #Kuch and Ballschmiter, 2001; 1Cargouët et al., 
2004; +Rurainski et al., 1977; 2Henriques et al., 2010; 3Wise et al. 2011; 4Jin et al., 2008 
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Even though these concentrations are low compared to other sources of EDCs that individuals 
encounter daily, it is still cause for concern that a mixture of highly physiologically active 
contaminants are included in drinking water and that the overall effect has not been determined 
conclusively. 
 
1.6.3 Implications of EDCs in the Environment 
There are many opinions as to whether or not the presence of endocrine disruptors in the 
environment causes any effects to an individual.  One view suggests that the minute amounts of 
these contaminants do not have any effect when compared to the overall concentrations of 
estrogenic substances that are consumed daily (Benotti et al, 2009; Westerhoff et al., 2005; Wise 
et al., 2011).  Yet another interpretation proposes that it is the complex mixture of many different 
EDCs and not the actual concentration which is harmful (Matthiessen, 2000).  Yet another 
interpretation of endocrine disruptors in the environment is that effects are more severe during 
developmental stages and that overall effects will not become apparent until future generations 
(Welshons et al., 2003; vom Saal, 1997).  The research that has been conducted to date has not 
provided a definitive answer as to which view is correct.   
 
This is an area where research design limits the possible conclusions.  Researchers have been 
focusing on different population groups which have provided different dose-response outcomes.  
For instance, if an adult is exposed to EDCs, then the effects will be minimal, if any, compared 
to prenatal or pre-puberty exposure.  Synergistic effects also impact the response to estrogenic 
contamination by either enhancing the biological activity of the mixture or decreasing the 
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biological activity of the mixture.  This change in activity is directly related to the combination 
of antagonists and agonists present in the mixture of contaminants. 
 
Environmental impacts have been observed in aquatic organisms and laboratory tests show 
animals responding negatively to exposures of EDCs.  Many have postulated that responses to 
environmental EDCs are manifest in the general population, such as low sperm count in males, 
increased infertility, increased obesity, increased diabetes and numerous other general population 
phenomenons.  These responses are discussed in Section 1.2 Exposure to Endocrine Disruptors. 
 
The Associated Press published articles on pharmaceuticals and personal care products in 
drinking water in the spring of 2008 (NPR, 2008; Donn et al., 2008).  The public became 
alarmed about this report, partly due to their concepts about drinking water treatment and also 
due to the manner in which the information was released.  Researchers have known of this 
contamination since the 1970s; however, the detection ability has greatly increased since that 
time (Rurainski et al., 1977).  The increasing amount of detection of EDCs is directly related to 
analytical power used to identify and quantify them; however, with the increase of surface and 
ground water contamination, drinking water will inevitably have an increase in contaminant load 
regardless of analytical ability. 
 
Since the consequences of having low quantities of EDCs in water are not completely known, it 
is imperative that changes to wastewater and drinking water treatment techniques be considered 
in order to optimize degradation, while keeping the original integrity of the treatment system.  
Without placing adequate attention on EDCs in the environment, we may reach a tipping point 
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where increased hormonal activity could do irreparable damage to our ecosystems and future 
generations. 
 
1.7 Conclusions 
The research reviewed in this introduction has provided a basis to warrant increased concern of 
estrogenic endocrine disruptor in the environment.  Along with reconceptualized dose-response 
curves and new findings in developmental biology (epigenetics), these latest interpretations have 
created a new understanding of the environmental health concerns associated with estrogenic 
compounds in drinking water.  
 
To the average healthy adult, estrogenic EDCs in drinking water may have little effect on the 
endocrine system.  To prepubescent children, however, the likelihood of adverse impacts 
increases due to the multiple biological mechanisms that are changing the body.  The biggest 
impact and most immediate concern from EDCs are the vulnerability of embryos and fetuses, 
because their rapid development is dependent on the endocrine system. 
 
With these issues in mind, the current research within the drinking water community needs to 
focus on the detection and quantification of these contaminants as well as identifying any 
byproducts associated with drinking water treatment to discern if more harmful contaminants are 
produced.  There are no existing methods that are universally used for estrogenic EDC detection 
and quantification in drinking water and the treatment byproducts have not been identified for all 
of the contaminants of concern.  Therefore, continuing research is needed to help in 
understanding the complete consequences of estrogenic endocrine disruptors in drinking water. 
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CHAPTER 2 Analytical Detection of EDCs in Drinking Water 
2 Analytical Methods 
2.1 Detection of EDCs in Drinking Water 
 
Due to the chemical diversity of endocrine disrupting compounds, the range of instrumental 
techniques available for their analysis is very large.  Within modern analytical techniques 
applicable to trace analysis of endocrine disrupting compounds (EDCs), gas chromatography 
(GC) and liquid chromatography (LC) in tandem with mass spectroscopy (MS) or with tandem 
mass spectroscopy (MS-MS), play an important role in providing sufficient selectivity and 
inherent sensitivity in the analysis of complex environmental matrices (Petrovic et al., 2004).  
Most of the analytical procedures developed for environmental determination of EDCs and 
emerging contaminants have been designed for analysis of specific classes of compounds.  
Analysis of each byproduct of individual EDCs will assist in developing multi-residue methods 
in which different compound classes can be identified in a single analysis. 
 
Driven by the estrogenic potency of these compounds and low environmental concentrations, the 
detection limits required for monitoring of EDCs are being pushed from microgram per liter 
(µg/L) to the nanogram per liter (ng/L) range and even to the picogram per liter (pg/L) range.  
The two most widely used forms of analysis, which can be used to accurately measure at these 
environmental concentrations, are GC-MS and LC-MS.  Gas chromatography-mass spectroscopy 
has not been customarily used in the analysis of EDCs because the LC-MS-MS analysis of 
estrogenic compounds is much faster and less affected by error (Petrovic et al., 2004).  Because 
the GC utilizes the gas phases during analysis, a derivitization step must be added during sample 
preparation to condition analytes from the liquid to gas phase change.   
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Liquid chromatography separates analytes based on their solubility in the mobile phase and their 
affinity to the stationary phase, or column.  Gas chromatography works on the same principles as 
the LC but uses a carrier gas phase instead of a mobile liquid phase.  This research utilized two 
LC-MS-MS systems to produce an identification and quantification method for estrogenic 
endocrine disruptors.  
 
The overall research goal using these analytical methods was to determine a suitable LC/MS/MS 
method for identification and quantification of estrogenic endocrine disruptors and their 
treatment byproducts.  To achieve this goal, two existing methods were compared and a new 
method was developed.  Once the treatment byproducts are identified, the method can be 
simplified or modified for less sensitive instruments to determine the EDC removal and by-
product presence.  It is anticipated that such degradation and detection techniques, 
supplementing the present drinking water purification procedures, will help to identify and 
prevent threats to water resources. 
 
2.2 Analytical Methods Background 
Due to the analytical challenges posed by low levels of EDCs in drinking water, new techniques 
for the detection and quantification of estrogenic compounds have been the subject of intense 
investigation.  From the wide variety of EDCs, these analytical methods focused on estrogenic 
EDCs, including estrone (Sigma-Aldrich, >99% purity), estriol (MP Biomedicals, >97% purity), 
β-estradiol (MP Biomedicals, >98% purity), 17β-ethynylestradiol (Sigma-Aldrich, >98% HPLC 
grade purity) and diethylstilbestrol (Sigma-Aldrich, 99% purity).  
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There are many protocols for measuring organic contaminants at trace levels in water, and most 
call for some pre-concentration, separation and cleanup.  SPE is one of the most widely used 
methods for pretreatment of these samples.  Because of the slow and laborious nature of most 
SPE protocols, there is great interest in ways of reducing time and cost in EDC analysis.  Several 
instruments which integrate automated SPE with LC/MS have been proposed for addressing 
these needs.  
 
This section discusses the differences in a manual method and an innovative approach using an 
automated SPE-LC-MS-MS for trace analysis of EDCs.  For this research the automated on-line 
system was the Waters AquaAnalysis System supplemented with a newly developed method.  
The manual off-line system used a Varian Elut SPS 24 extraction manifold with Dryfast Vacuum 
Pump and Waters Alliance 2695 Separation Module coupled to a Waters Quattro microTM API 
Quadrupole Mass Spectrometer.  The manual method was based on EPA 1694 Method: 
Pharmaceuticals and Personal Care Products in Water, Soil, Sediment and Biosolids by 
HPLC/MS/MS, which is an accepted method for measuring PPCPs; this method, however, does 
not include estrogenic EDCs (2007).  Both methods used the same type of LC separation column 
(Waters C-18 Atlantis® T3, 3µm 2.1x50mm Column) and the same mass spectrometer.  The 
solid phase used in the SPE was the Waters Oasis® Hydrophilic-Lipophilic Balance (HLB) 60 
µm extraction cartridges for both methods.  The HLB cartridge contains a resin made from a co-
polymer of divinybenzene and vinyl pyrrolidinone, which acts as an imbedded hydrophilic group 
and enhances retention of analytes (Young et al., 1999).  Thus, the only features compared 
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between methods were the quality and efficiency of sample preparation and sample introduction 
to the analytical instrumentation. 
 
The performance of sample preparation and introduction was compared using the coefficients of 
determination, relative standard deviations and signal-to-noise ratios.  The coefficient of 
determination (R2) is the proportion of variability within a sample set using a linear regression 
model (Sen et al., 1990). 
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Equation 2-1 
 
Both low concentration and high concentration calibration curves were used to find a coefficient 
of determination.  The low concentration included 1.0 ppt to 100 ppt and the high concentration 
included 25 ppb to 100 ppb. 
 
The signal-to-noise ratio (S/N) is the ratio of the peak height (from a given mass load) to 
baseline noise (Young et al., 1999).  The minimum quantfication limits (MQLs) were determined 
based on the lowest concentration where chromatographic peaks had a signal-to-noise ratio of 
10:1 or higher.  The minimum detection limits were selected based on the lowest level at which 
an analyte could be detected, which was defined as a S/N of 2:1 or 3:1. 
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The relative standard deviation is the absolute value of the coefficient of variation (Sen et al., 
1990).  This measurement was used to compare the instrument variability in different injections 
of the same sample and was expressed as a percent.  
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Equation 2-2 
 
The following sections further discuss and expand on the benefits and limitations of the off-line, 
manual methods and the on-line, automated method.  This comparison was necessary because of 
the lack of standard methods and the enormous cost and effort required in measuring and 
monitoring EDCs. 
 
2.3 Soild Phase Extraction Introduction 
Solid-phase extraction (SPE) is an established technique that is routinely used for the 
extraction/concentration of target compounds and for removing interference from matrix 
components prior to chromatographic analysis (Alda et al., 2003; Richardson and Ternes, 2005; 
Wells et al., 1987).  This sample pretreatment method is used to enhance the analytic signal to 
quantitatively analyze contaminants with liquid chromatography/mass spectroscopy.  
 
SPE is commonly used for extraction of EDCs from environmental matrixes and operates on the 
principles of solubility and solid phase affinity of each analyte.  The process includes the 
removal of organic contaminants from water and adsorbing them onto a solid phase followed by 
extraction and elution to concentrate the samples.  Pre-extracted sample sizes typically range 
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from 500 mL to 1 L, with a final sample volume of 1 mL.  The pre-sample size is based on the 
cost and practicality of the sample volume and the enhancement factor desired in the extracted 
sample.  The solid phase employed in the extraction can vary widely based on the structure and 
composition of the analytes and can be contained in either cartridges or barrels depending on 
whether the system is off-line or on-line.  Figure 2-2 shows the SPE steps when using a cartridge 
for the off-line method.  The same procedures are used for on-line SPE systems; however, 
software programs control the loading, washing and extraction instead of the operator. 
 
Target
Compounds
Column
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Eluted
Interferences
Sample
Loading
Target 
Compound Elution
Column
Washing
 
Figure 2-1:  Solid Phase Extraction Using Columns  
(adapted and modified from www.biotage.com) 
 
Column solvation refers to the conditioning of the column to prepare the solid phase for sample 
loading.  Depending on sample size, the sample loading step can require a considerable time to 
complete.  With increased sample size, there is an increase in final concentration; therefore, 
sample extractions tend to result in a 1000 fold reduction in sample size and 1000 fold increase 
in analyte concentration, presuming complete recovery.  Column washing prior to elution is an 
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extremely critical step used to decrease interference in MS analysis of target compounds.  If this 
step is ignored, then the interfering compounds are also increased along with the analyte, causing 
increased signal-to-noise, false elevated signal intensity during analysis, or charge suppression in 
LC/MS. 
 
There are many types of SPE available in the laboratory.  The off-line manual extraction uses a 
vacuum manifold to draw the raw sample through SPE cartridges and manually administer 
column washing solvents and the elution solvents.  After the 1 mL extracted sample is collected, 
a fraction of that sample is separated and analyzed using LC-MS.  This SPE method is extremely 
laborious and there are many points within the numerous steps where error can be introduced. 
 
For automated SPE devices, there are two forms available; automated off-line SPE excluding a 
detection system and automated online SPE including a detection system.  The off-line SPE, 
excluding the detection system, uses software to control pumps and solvents to perform the same 
extraction as the manual method, with the raw sample being reduced to the 1 mL extracted 
sample.  A fraction of this extracted sample is then injected into the detection system to be 
separated and analyzed.  The on-line SPE system with a detection system also uses software to 
control solvents and samples introduced to the SPE columns, which are usually barrels made 
with the same solid phase as the cartridges.  The “extracted” sample is then eluted off the barrel 
and the entire sample is separated and analyzed using LC-MS.  Both of the automated SPE 
methods reduce operator error; however, the on-line version has further benefits in the increased 
size of the sample used in the analysis.   
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2.4 Molar Absorption Coefficients 
2.4.1 Introduction to Molar Absorption Coefficients 
Molar absorption coefficients can be used to verify concentrations of analytes measured by 
LC/MS/MS when the absorbance chromatograms are isolated from the total ion chromatogram.  
Molar absorption coefficients, ε(λ), are determined by measuring the absorbance of pure 
solutions at various known concentrations in a 1 cm path length cuvette and performing a linear 
regression of the absorbance at each wavelength versus concentration according to the Beer-
Lambert Law shown in Equation 2-3 (Schwarzenbach et al., 2003).   
 
][)()( EDCbA λελ =  Equation 2-3 
 
Determining the molar absorption coefficients allowed solution concentrations to be validated by 
taking the UV absorbance of the EDC solution at the wavelength that corresponds to the local 
maximum calculated coefficient. 
 
2.4.2  Molar Absorption Coefficients Methods 
Since the estrogenic EDCs being studied have a multiple ring structure, their absorbance spectra 
have multiple local maxima and they have a unique curve associated with phenols.  An Agilent 
8453 UV spectrophotometer was used to measure the UV absorbance at wavelengths from 190 
nm to 400 nm.  The molar absorption coefficient curves were determined using a linear 
regression function, utilizing a range (1 to 10 mg/L) of known concentrations of each EDC in 
deionized water and their corresponding absorbance spectra.  To produce an exact, known 
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concentration, the individual EDCs were first dissolved in methanol at 1.00 mg/mL 
concentrations and then serially diluted in water to the appropriate concentrations.  It was 
assumed that after the dilutions, the methanol concentration was negligible.  The corresponding 
molar absorption coefficient curves are shown in Figure 2-2. 
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Figure 2-2:  Estrogenic EDCs Molar Absorbance Spectra 
 
The molar absorbance curves in Figure 2-2 follow similar patterns of two local maxima at 220 
nm and 280 nm, which is due to the multiple ring structure for the estrogenic compounds.  DES 
is the exception with only one local maxima at 240 nm because both rings are phenols and have 
similar vibration and rotation states due to the symmetry of the compound.  Table 2-1 provides 
the maximum molar absorption coefficients and the corresponding wavelengths for each analyte.   
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Table 2-1:  Molar Absorption Coefficients for Estrogenic EDCs 
 Wavelength, λ  
(nm) 
Molar Absorption Coefficient, ε  
(M-1cm-1)∗ 
Estrone 220 280 
12,738 
4,173 
β-Estradiol 220 280 
8,676 
3,563 
Estriol 220 280 
6,636 
1,680 
17β-Ethinylestradiol 220 280 
8,430 
2,131 
Diethylstilbestrol 240 12,753 
*Values agree with Mazellier et al. for EE2 (2008), Puma et al. for E3 (2010), Merck Index for 
DES (2006).  Absorption coefficients for E1 and E2 agree with Hurwitz and Liu, 1977; however, 
they do not agree with Puma et al. (2010). 
 
2.4.3 Molar Absorption Coefficient Applications 
For E1, E2, E3 and EE2, the molar absorbance intensities vary due to the differing functional 
groups on the C17.  The differing moities have small effects on the overall spectra, which are 
dominated by the multiple ring structure.  Because of these characteristic absorbance curves, 
when the ring is broken during a chemical reaction, the absorbance spectra for the byproducts are 
noticeably different from the parent compound.  The differences between the parent and 
byproduct absorbance spectra could connote changes in functional groups or alterations in ring 
structures. 
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2.5 AquaAnalysis Method 
2.5.1 AquaAnalysis Method Background 
The Waters AquaAnalysis is a parallel on-line sample prep plus separation and detection system.  
The extraction portion of the on-line system implements reusable Oasis® HLB barrels (>4000 
injections) (Mallet, 2008).  The SPE and analytical instrument processing method had an 
injection volume of 5 mL and a combined run time of 20 minutes.  Larger amounts of sample 
can be introduced to the system; however, a 5 mL sample size was chosen based on the extracted 
sample size reduction used in the manual SPE method, which is discussed Section 2.6 EPA 1694 
Method.  The typical sample vial for the AquaAnalysis was 20 mL in volume but the Waters 
2777C Sample Manager Autosampler software program could load any volume needed by 
delaying the inlet start method.  When 5 mL of 10 ppt EDC contaminated water was injected into 
the system, then the entire 50 pg enters the SPE and LC separation systems.  
 
2.5.2 AquaAnalysis Method Results 
Table 2-2 lists the mass spectrometer optimizations values used for both the automated, on-line 
method and the manual, off-line method.  Appendix A includes more detailed MS settings for 
both methods. 
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Table 2-2:  MS/MS Optimizations for Estrogenic EDCs 
 
MW  
(g/mol) 
ESI# 
Mode 
Precursor 
Ion 
Cone 
Voltage 
(V) 
MRM* 
Transition 
(m/z) 
Collision  
(eV) 
Estrone (E1) 270.37 (-) 269.3 50 269.3 / 145.3 30 
β-Estradiol (E2) 272.38 (-) 271.3 50 271.3 / 145.3 35 
Estriol (E3) 288.38 (-) 287.1 55 287.1 / 171.0 35 
17β-Ethinylestradiol (EE2) 296.41 (-) 295.2 50 295.2 / 145.2 40 
Diethylstilbestrol (DES) 268.35 (-) 267.1 40 267.1 / 251.2 25 
#Electrospray Ionization (ESI); *Multiple reaction monitoring (MRM) 
 
Figure 2-3 is the LC chromatogram with the five separate MRM transitions and Table 2-3 
presents the retention times, MQLs, MDLs, high concentration curve R2 and the low 
concentration curve R2 for the five MRM transitions.  The complete list of method parameters 
and steps are listed in Appendix A. 
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Figure 2-3:  Automated, On-line SPE Method Chromatogram with Separated MRMs 
 
Table 2-3:  AquaAnalysis Detection Limits for Estrogenic EDCs 
 
Retention 
Times 
(min) 
Minimum 
Quantification 
Limits 
(MQLs) 
Minimum 
Detection 
Limits 
(MDLs) 
High 
Level R2 
Low 
Level R2 
Estrone (E1) 6.4 5 ppt 2.5 ppt 0.9757 0.7474 
Estradiol (E2) 5.9 10 ppt 1.0 ppt 0.9846 0.8318 
Estriol (E3) 3.9 2.5 ppt 1.0 ppt 0.9916 0.6908 
17β-Ethinylestradiol 
(EE2) 6.8 10 ppt 2.5 ppt 0.9777 0.9836 
Diethylstilbestrol 
(DES) 
6.3 
9.2 2.5 ppt 2.5 ppt 0.9920 0.5315 
 
There were two peaks associated with the DES analyte because of the stereoisomeric impurities 
in the purchased solid stock samples.  Both peaks associated with DES were used to determine 
the concentration, MDL and R2 by adding the peak areas together, then the analysis was 
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preformed on the sum.  The same procedure was used for the EPA 1694 Method so that results 
were comparable. 
 
Another value used to understand the difference in methods is the repeatability in sample 
quantification.  The RSD% was calcuated for three injections from the same sample vial at 25 
ppt, 50 ppt and 100 ppt.  Table 2-4 contains the RSD% for each estrogenic EDC. 
 
Table 2-4:  AquaAnalysis Relative Standard Deviations for Repeated Injections 
  
Relative Standard Deviations between Multiple Injections (%) 
Estriol Estradiol Estrone Ethinylestradiol Diethylstilbestrol 
25 ppt 4.71 4.36 5.59 3.41 5.65 
50 ppt 17.59 18.14 28.60 28.07 6.84 
100 ppt 5.14 6.14 6.70 4.82 8.52 
 
2.6 EPA 1694 Method 
2.6.1 EPA 1694 Method Background 
Since the published EPA 1694 Method does not include EDCs, the procedures for the acidic 
extraction had to be modified for the estrogenic compounds.  Deviations from the published 
method include, not acidifying the raw sample or the preparation of the HLB column and not 
adding EDTA to the raw sample.  These steps were excluded because the methods used in this 
study consisted of deionized water with known spiked contaminants in order to compare 
methods.  
 
An initial spiked raw water sample size of 1000 mL was concentrated to 4 mL using the HLB 
column.  It was not apparent as to why the samples in the EPA 1694 Method were concentrated 
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to 4 mL instead of 1 mL, when the autosampler vials hold 1 mL and a decreased extracted 
volume leads to increased sample concentration.  The HLB extraction cartridges were one-time 
use only and the complete extraction time was 8 hours in duration.  The instrument run time was 
16 min using the LC-MS-MS system and an injection volume of 15 µL.  Therefore, the 
extraction of a 10 ppt EDC sample of 1L leads to 2,500 ppt in 1mL sample vials and 37.5 pg 
injected into the instrument.  The concentrations listed for the EPA Method refer to the original 
sample concentration in 1 L water prior to extraction.   
 
2.6.2 EPA 1694 Method Results 
Figure 2-4 is the EPA 1694 Method LC chromatogram with the five separate MRMs and Table 
2-5 shows the retention times, MQLs, MDLs, high concentration curve R2 and the low 
concentration curve R2 for the five MRM transitions.  The complete list of method parameters 
and steps are listed in Appendix A. 
 
53 
 
Time (min)
0 2 4 6 8 10 12 14 16
In
te
n
sit
y
0
1000
2000
3000
4000
5000
6000
7000
Estriol 
Estradiol 
Estrone 
Ethinylestradiol 
Diethylstilbestrol 
  
Figure 2-4:  Manual Off-line SPE Method Chromatogram with Separated MRMs 
 
Table 2-5:  EPA 1694 Method Detection Limits for Estrogenic EDCs 
 
Retention 
Times  
(min) 
Minimum 
Quantification 
Limits  
(MQLs) 
Minimum 
Detection 
Limits  
(MDLs) 
High 
Level R2 
Low 
Level R2 
Estrone (E1) 3.1 2.5 ppt 1.0 ppt 0.9940 0.8472 
Estradiol (E2) 2.7 30 ppt 5 ppt 0.9954 0.7784 
Estriol (E3) 1.1 2.5 ppt 1.0 ppt 0.9804 0.8735 
17β-Ethinylestradiol 
(EE2) 3.3 20 ppt 5 ppt 0.9954 0.7784 
Diethylstilbestrol 
(DES) 
5.2 
7.2 1.0 ppt 1.0 ppt 0.9602 0.8370 
 
The RSD% was calcuated for three injections from the same sample vial at 25 ppt, 50 ppt and 
100 ppt.  Table 2-6 presents the RSD% for each estrogenic EDC. 
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Table 2-6:  EPA 1694 Method Standard Deviations for Repeated Injections of Estrogenic EDCs 
  
  
  
Relative Standard Deviations between Multiple Injections 
Estrone Estradiol Estriol Ethinylestradiol Diethylstilbestrol 
25 ppt 9.75 173.21* 12.71 173.21* 18.90 
50 ppt 16.65 4.00 9.28 14.43 4.03 
100 ppt 5.68 16.48 6.38 15.92 7.80 
*These RSD% are very large due to both no-dection and small-detection within the same sample. 
 
2.7 Identification of Treatment Byproducts with Optimized Method 
2.7.1 Optimized Method Background 
The new method was optimized for EE2 and DES at both high and low concentrations.  Because 
of the optimized detection and quantification along with the target levels needed for the 
byproduct identification experiments, SPE was not needed.  Therefore, this method was 
developed on the Waters Alliance 2695 Separation Module coupled to a Waters Quattro microTM 
API Quadrupole Mass Spectrometer using a Kromasil® C-18, 3.5µm 4.6x150mm Column.  This 
method also utilized the Waters 2996 Photodiode Array Detector attached to the Alliance prior to 
MS sample introduction.  If SPE was needed, then the AquaAnalysis system would be used.  If 
the manual method was the only one available, then an extraction of 10 ppt EDC in raw water (1 
L) should become 10,000 ppt in 1mL sample vials and 1 ng in a 100 µL injection, assuming 100 
% recovery. 
 
The previous methods did not provide absorbance chromatograms, which required the 
identification process to rely solely on the chromatography and MRMs.  Since DES and EE2 
have distinct absorbance curves with local maxima at different wavelength, the addition of a 
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PDA decreased the variability in sample signal, by comparing chromatograms, mass spectra and 
absorbance spectra.   
 
2.7.2 Optimized Method Results 
Figure 2-5 and Figure 2-6 are the LC chromatograms of the separate MRMs for EE2 and DES.  
Table 2-7 shows the retention times, MQLs, MDLs, high concentration curve R2 and the low 
concentration curve R2 for the two MRM transitions.  The complete list of method parameters 
and steps are listed in Appendix A. 
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Figure 2-5:  Optimized Method Chromatogram with Separated EE2 MRM 
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Figure 2-6:  Optimized Method Chromatogram with Separated DES MRM 
 
Table 2-7:  Optimized Method Detection Limits for Estrogenic EDCs 
 
Retention 
Times  
(min) 
Minimum 
Quantification 
Limits  
(MQLs) 
Minimum 
Detection 
Limits  
(MDLs) 
High 
Level R2 
Low 
Level R2 
17β-Ethinylestradiol 
(EE2) 17.49 
13.3 ppt 
(0.045 µM) 
13.3 ppt 
(0.045 µM) 0.9727 0.9880 
Diethylstilbestrol 
(DES) 
16.97 
17.89 
2.68 ppt 
(0.01 µM) 
>2.68 ppt 
(>0.01 µM) 0.9821 0.9714 
 
The RSD% was calcuated for three injections from the same sample vial at 5 µM, 8 µM and 10 
µM.  Table 2-8 holds the RSD% for EE2 and DES. 
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Table 2-8:  Optimized Method Standard Deviations for Repeated Injections of Estrogenic EDCs 
 
 
 
Relative Standard Deviations between Multiple Injections 
17β-Ethinylestradiol Diethylstilbestrol 
5 µM 0.72 4.60 
8 µM 0.99 4.62 
10 µM 1.02 1.66 
 
This optimized method decreased the RSD% significantly compared to the EPA 1694 and 
AquaAnalysis methods because of the PDA addition.  The PDA also decreased the MQLs and 
MDLs because specific wavelengths could be isolated from the LC chromatogram and then 
manipulated.  The increased sample injection volume was also responsible for the decreased 
MQLs and MDLs, which is based on the principle that increased sample injection volume will 
always give an increased signal.   
 
2.8 Discussion of Methods 
The manual method was a very labor intensive extraction technique producing MQLs of 30 ppt 
or lower for the estrogenic EDCs.  The AquaAnalysis was less time consuming to operate and 
produced MQLs of 10 ppt or lower with only 5 mL sample injection.  Developing a new method 
for the AquaAnalysis was time intensive; however, once a method was optimized, then the 
sample run times decreased dramatically and the instrument could be run when the operator was 
not present due to the system’s automated capabilities.  The manual method may have had 
significantly higher MQLs due to the more intense manipulation of the samples by the operator 
and due to the systematic error of the multiple step extraction. 
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The method comparison also showed a decrease in error when using the automated version in the 
higher concentration range when compared to the manual version because of the elimination of 
sample transfers and possible contaminants entering the samples throughout the extraction steps. 
When comparing the low range concentrations, the EPA 1694 Method produced similar 
detection limits with better reproducibility than the AquaAnalysis system.  Both methods 
reported high R2 values for the high concentrations, but overall the EPA 1694 Method produced 
calibration curves at the low concentrations that better fit the linear estimation between the 
concentrations and the peak areas. 
 
A significant decrease in cost was also noted when using the automated extraction due to the 
decrease in labor expenditures and in the cost of SPE cartridges.  Since the automated method 
required less raw sample, there was a large reduction in cost for sample collection and shipment 
even prior to extraction.  There was however considerable cost associated with the solvent 
needed to operate the system compared to the manual method’s requirements.  The 
AquaAnalysis system was initially more expensive than the instrumentation for the EPA 1694 
Method; however, there was a large savings in decreased labor costs. 
 
Overall, both methods were comparable in analyte detection and quantification with some 
differences in the performance on individual EDC basis.  With the increased efficiency of sample 
preparation and decreased raw sample volumes, the AquaAnalysis system has high potential in 
any analytical discipline.  There are improvements, however, that were applied to the methods 
and the instrumentation for both the AquaAnalysis system and the EPA 1694 Method.  
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The optimized method was produced based on the AquaAnalysis and EPA 1694 Method results 
and focus shifted towards two analytes at low concentrations and high concentrations, which 
were required for EDC treatment and byproduct studies.  The optimized method decreased 
sample variability; showed a better fit to a linear calibration with both high and low 
concentrations; and lower MQLs and MDLs. 
 
2.9 Conclusions 
The AquaAnalysis and EPA 1694 methods were comparable in analyte detection and 
quantification with differences in the performance on individual EDC basis.  The AquaAnalysis 
system promises increased efficiency of sample preparation and decreased raw sample volumes.  
There were improvements applied to the methods and the instrumentation for both the 
AquaAnalysis system and the EPA 1694 Method to produce an optimized method.  
 
With the molar absorption coefficients and the absorbance chromatograms, the optimized 
method decreased sample variability between injections.  The optimized method also provided a 
higher R2 in the linear calibration with both high and low concentrations.  Compared to the 
AquaAnalysis and EPA 1694 methods, the optimized method also lowered the method 
quantification limits and the method detection limits.   
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CHAPTER 3 Endocrine Disrupting Compounds and their 
Disinfection Byproducts 
3 EDCs in Drinking Water Treatment 
3.1 Background on EDCs in Drinking Water 
The first detection of steroidal hormones in natural waters was documented by Tabak and Bunch 
in 1970 with a study entitled “Steroid Hormones as Water Pollutants”.  These estrogenic 
contaminants were found to enter the environment by multiple pathways, including the largest 
source, human and animal excretion.  These compounds exit the body in conjugated forms, 
which are then deconjugated within the wastewater treatment process.  After discharge into 
surface waters, these hormonally active contaminants have the potential of entering drinking 
water sources. 
 
Even though there is a contentious debate over the impacts of these compounds, it is useful to 
determine their presence in drinking water, because of the variations in initial concentrations and 
removal efficiencies.  With this in mind, it is incumbent upon the drinking water research 
community to continue to identify and quantify EDCs to determine possible present and future 
impacts. 
 
There have been numerous studies devoted to endocrine disruptors and their kinetic reactions 
during disinfection treatments.  Few drinking water treatment techniques for the removal of 
estrogenic compounds, however, have been compared for treatment effectiveness and byproduct 
formation.  Since the primary goal of disinfection is to remove or inactivate pathogenic 
microorganisms, the removal of EDCs from drinking water has customarily been on secondary 
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concern.  However, the future consequences on ignoring these contaminants could be significant, 
even though major effects may not be observed until later generations.  It is imperative, 
therefore, that the parent compounds and the resultant treatment byproducts be identified to 
determine the specific contaminants, which contribute to the overall estrogenic activity.   
 
Identification of EDCs present in drinking water is an integral step in comparing the removal 
ability of disinfection techniques.  Using liquid chromatography/mass spectroscopy, the 
identification and quantification of parent estrogenic compounds can be obtained as well as the 
identification of treatment byproducts and their concentrations relative to the decrease in each 
parent compound. 
 
The steroidal activity of environmental estrogens can only be accurately determined through 
bioassays, which target estrogenic hormones.  In the absence of bioassays, estrogenic activity can 
be approximately determined by comparing structures similar to the parent estrogenic compound.  
By structure alone this class of estrogenic contaminants is present in numerous molecular shapes 
and sizes; therefore, comparison to the parent compound with its specific moieties is a 
rudimentary but effective method. 
 
The following sections discuss the possible removal processes that may be employed in the 
removal of estrogenic contaminants.  These selected removal techniques were applied to 
synthetic estrogens ethinylestradiol and diethylstilbestrol.  The synthetic estrogens were selected 
based on their relative estrogenic strength in comparison to natural estrogens and their observed 
emergence as contaminants in drinking water (See Literature Review, Chapter 1). 
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3.2 Selected Removal Processes 
Numerous treatment techniques are used for drinking water disinfection.  The primary goal for 
disinfection is to protect the public from waterborne diseases by employing water treatments to 
reduce the concentration of pathogenic organisms through inactivation and/or removal 
(Crittenden et al., 2005).  These disinfection techniques are customarily organized into two 
categories: primary and secondary.  Primary disinfection refers to the inactivation of 
microorganisms and secondary disinfection describes the residual disinfectant applied to water 
destined for the distribution network.  A typical primary disinfectant is a strong oxidizer, while 
the secondary disinfectant is a weak oxidizer. 
 
The chemical oxidation process is also used to reduce inorganic contaminants, hazardous 
synthetic organic compounds and active steroidal chemicals (Singer and Reckhow, 2011).  The 
oxidation reactions are heavily dependent on the pH of the system, due to the different oxidation 
states of the species present at various pHs.  The rates of the oxidation reactions are also 
dependent on the pH, as well as the system temperature, number of species present and types of 
species present in the reaction.  The strength and rate of an oxidation reaction can also determine 
which disinfectant is used in a treatment system, based on system limitations and requirements, 
such as required disinfectant concentration and contact time (C·t).  Taste and odor problems can 
also be addressed by the use of chemical oxidation.   
 
A widespread concern in using chemical oxidants is the formation of disinfection byproducts 
(DBPs).  The choice of oxidant implemented in water treatment plants is directly related to the 
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raw water quality, including total organic carbon, organic halides, and type of microbiological 
activity.  The EPA has set limits on selected chlorination DBPs due to the carcinogenic qualities 
of many of these contaminants (Safe Drinking Water Act: EPA 816-F-09-0004, 2009). 
 
This research focused on chlorination, chloramination and ozonation disinfection treatment 
processes.  There are numerous other techniques that could be used in the removal of EDCs 
through drinking water treatment; however, the selected chemical disinfection processes are the 
most widely used disinfection treatment techniques.   
 
Figure 3-1 shows a simplified schematic of drinking water treatment.  The disinfection step was 
the process studied in this research.   
 
 
Figure 3-1:  Diagram of Drinking Water Treatment Plant (Davis and Masten, 2004) 
 
3.2.1 Chlorination 
Chlorination is the most widely used disinfection process in drinking water treatment in the 
United States.  Chlorine is a strong oxidizing agent that is operator-friendly, inexpensive and a 
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reliable disinfectant.  For drinking water, chlorine can be introduced as either chlorine gas 
(Cl2(g)), sodium hypochlorite (NaOCl) or calcium hypochlorite (Ca(OCl)2) (Masters, 1997).   
 
When chlorine gas is added to pure water, the species resulting from the dissociation of Cl2 are 
hypochlorous acid (HOCl) and hypochlorite ion (OCl-).  The primary disinfecting agent in the 
chlorination process is HOCl, while OCl- is a less effective disinfectant.  The pKa for HOCl is 
7.54; therefore, the strength of the disinfecting agent present is based on the pH and the 
corresponding chlorine oxidation state.  The reaction temperature also dictates the rate of the 
reaction, with warmer water causing the dissociation of hypochlorous acid to occur at a slightly 
lower pH (Crittenden et al., 2005).  The dissociation equilibria for chlorine in water are shown 
below. 
 
Cl2 + H2O HOCl + Cl- + H+ ClO- + H+
 
Reaction 1 
 
The primary advantage of using chlorine as a disinfectant is that after the initial reaction, the 
treated water can retain a chlorine residual, which can help protect the quality of drinking water 
throughout the distribution system.  According to the Safe Drinking Water Act, regulated by the 
EPA, the maximum allowable level of chlorine residual as Cl2 is 4.0 mg/L.  With high levels of 
Cl2 residual, there is potential for irritation to eyes and nose, as well as stomach discomfort 
following long term exposure (SDWA, 2009). 
 
Even though chlorine is relatively stable in pure water, it has a slow reaction rate with natural 
organic matter (NOM) found within drinking water.  There have been numerous studies on 
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chlorination DBPs; however, there are no fundamental (i.e. non-empirical) reaction rates 
available for HOCl and NOM because of the variability in NOM composition (Crittenden, 2005). 
 
The disadvantage of using chlorine as a disinfectant is the formation of trihalomethanes (THMs) 
and haloacetic acids (HAAs), as well as other chlorination DBPs.  These chlorinated DBPs have 
been implicated in damaging internal organs and increasing the risk of cancer (Masters, 1997).  
Since these DBPs are formed from a reaction between natural organic matter and chlorine, the 
concentration of THMs and HAAs is directly proportional to the amount and type of natural 
organic matter in the treated water.  Therefore, THM and HAA concentrations can be decreased 
with organic removal during treatment before chlorination (Morris and Isaac, 1981). 
 
The EPA drinking water regulations (EPA 816-F-09-0004) for the presence of DBPs has been set 
at MCLs of 0.060 mg/L for HAA5 and 0.080 mg/L for total THMs (SDWA, 2009).  The 
TTHMs, and the corresponding MCLs, include bromodichloromethane (zero), bromoform 
(zero), dibromochloromethane (0.06 mg/L), and chloroform (0.07 mg/L), where the MCLGs are 
given in parentheses (SDWA, 2009).  The five haloacetic acids in HAA5, and the corresponding 
MCLs, include dichloroacetic acid (zero), trichloroacetic acid (0.02 mg/L), monochloroacetic 
acid (0.07 mg/L), bromoacetic acid (N/A) and dibromoacetic acid (N/A).  With long-term 
exposure, HAA5s increase risk of cancer and TTHMs are implicated in liver and kidney failure, 
nervous system problems and increased risk of cancer (EPA, 2009). 
 
Since chlorination is the most widely used disinfection process, there have been numerous 
studies on the treatment byproducts resulting from reactions of free chlorine with EDCs.  The 
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chlorination of EE2 has produced numerous byproducts that retain the estrogenic qualities of the 
parent compound, with the major byproducts being identified as 4-chloro EE2 and 2,4-dichloro 
EE2 (Alum et al., 2004; Hu et al., 2003; Moriyama et al., 2004).   
 
The Deborde et al. (2004) study determined the reaction rates for the chlorination of EE2, where 
k1 = 2.04 x 105 M-2s-1; k2 = 4.33 M-1s-1; k3 = 3.52 x 105 M-1s-1, for the following second order 
reactions: 
 
                                ED + HOCl + H+  byproducts                        k1 
                  ED + HOCl  byproducts              k2 
                 ED- + HOCl  byproducts             k3 
Reaction 2 
 
Deborde et al. found t1/2 of 73.2 min for the removal of EE2 with a chlorine dose of 0.1 mg/L 
and t1/2 of 7.3 min for the removal of EE2 with a chlorine dose of 1 mg/L (2004). 
 
There has been no published research on the chlorination of DES that discusses the reaction rates 
or the byproducts produced, along with the respective estrogenic qualities of the byproducts; 
however, Lee and Morris (1962) published kinetics of the chlorination of phenol.  This 
publication was used along with Larson and Weber’s (1994) discussion on chlorination of 
phenols to determine the identities of the byproducts produced for both the chlorination of EE2 
and DES.  Since a lack of data is available, it is necessary to identify the byproducts and their 
relative concentrations prior to determining their estrogenic qualities and/or their formation rates. 
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3.2.2 Chloramination 
Chloramination reactions with estrogenic contaminants have not been studied as thoroughly as 
other oxidation reactions used in drinking water treatment.  To increase the lifetime of the 
residual chlorine disinfectant, some drinking water utilities add ammonia to finished water, 
forming chloramines; monochloramine (NH2Cl), dichloramine (NHCl2), and trichloramine 
(NCl3).  There are four types of chloramination, which differ based on the order of ammonia and 
free chlorine introduction: pre-ammoniation, pre-chlorination, simultaneous addition and pre-
formed chloramines.  
 
Chloramines have a much lower reaction rate compared to the chlorination reaction rates with 
organic contaminants and are typically used as a secondary disinfectant.  The primary purpose 
for chloramine addition is to control microbes (EPA, 2009).  There are potential long-term 
chloramine exposure effects, such as anemia, eye and nose irritantation and stomach discomfort 
(EPA, 2009).  According to the SDWA, the MRDL for chloramines as Cl2 is 4.0 mg/L. 
 
 
Reaction 3 
 
Since the published research on chloramination reactions with estrogenic compounds is limited, 
daughter products formed from the reactions have not been identified for any estrogenic EDCs.  
If the chloramine formation rate is slower than the free chlorine reaction rate with the estrogenic 
compounds, then the same daughter products will be produced as discussed in the free chlorine 
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reaction.  Conversely, if the chloramine formation rate is faster than the free chlorine reaction 
rate with the contaminant, then new daughter products may be formed.  Since the reaction rates 
and products for chlorine and ammonia are pH dependent, the daughter products produced will 
consequently depend on the pH of the system.   
 
The reaction rate constant between the un-ionized species HOCl and NH3 is 4.17 x 106 M-1s-1 at 
pH 7 and 25 oC (Morris and Isaac, 1981) compared to the apparent reaction rate constant of 
HOCl and ethinylestradiol at pH 7 and 20 oC of 1.12 x 102 M-1s-1 (Deborde et al., 2004).  Even 
though the comparison of reaction rates indicates that the byproducts will not form, there is 
potential for byproducts to be observed based on the order of ammonia and free chlorine 
additions; specifically pre-chlorination and simultaneous addition chloramination reactions. 
 
There is no published research on the chloramination of DES or EE2.  Chloramination is widely 
used, however, as a secondary disinfectant and could result in byproduct formation within a 
distribution system.  The reaction rates with chloramines are relatively slow compared to other 
types of disinfectants. 
 
3.2.3 Ozonation 
Ozonation involves the dissolution of ozone (O3) in water, providing a very powerful disinfectant 
that is even more effective against cysts and viruses than chlorine (Masters, 1997).  Ozone also 
has the added advantage of leaving only inconsequential taste or odor problems. Although 
ozonation is widely used in European water treatment facilities, it has the disadvantage of not 
forming a protective residual in the treated water and the process is more expensive than 
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chlorination. The level of bromate in drinking water is regulated, thus ozone can not be used if 
high levels of bromide are present in the water source.  Compared to chlorination, the use of 
ozone decreases trihalomethane formation, and helps control taste and odor problems (Viessman 
and Hammer, 2005).   
 
The following reactions show the intermediates in the ozone reaction with water (Masters, 1997). 
 
O3 + OH- HOO- + O2 HOO + O3-
HOO H+ + O2 - O2 - + O3 O2 + O3 -
O3 - + H2O HO + HO- + O2
O3
 
Reaction 4 
 
 
Reactions with ozone and EDCs are quite rapid as well.  Huber et al. (2003) presented a second 
order rate constant for the reaction of ozone with 17α-ethinylestradiol that is near the diffusion 
limit.  Given the pKa of the phenolic moiety, ethinylestradiol would degrade in a fraction of a 
second, even in the presence of a low ozone residual due to the destruction of the ring structure 
by oxygen radicals.  With similar structures at the point of attack, it is expected that other 
estrogens are similarly reactive with ozone; however, Huber et al. (2004) found estrone to have a 
decreased removal efficiency in wastewater as compared to either estradiol or ethinylestradiol.   
 
The potential toxicity of EDC degradation byproducts have been studied only after ozonation 
where the phenol ring remained intact and the estrogenic activity was decreased (Huber et al., 
2004).  The Deborde et al. (2005) study determined the reaction rates by competition kinetics for 
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the ozonation of EE2, where k1 = 1.83 x 105 M-1s-1and k2 = 3.65 x 109 M-1s-1, for the following 
second order reactions: 
 
                     ED + O3  byproducts            k1 
                  ED- + O3  byproducts        k2 
                 ED-2 + O3  byproducts         k3 
Reaction 5 
 
Hashimoto et al. found 90 % removal of EE2 with an ozone dose of 1mg/L and 100 % 
degradation of EE2 with a dose of 3 mg/L O3 (2006); however, byproducts were not identified in 
this study. 
 
The ozonation of EE2 has been shown to produce numerous byproducts that maintain the 
estrogenic activity of the parent compound by retaining the phenolic moiety, which acts as the 
estrogen receptor binding site (Deborde et al. 2005; Dodd et al., 2006; Huber et al., 2005; 
Nakonechny et al., 2008).  Lee et al., 2008 suggest that a hydroxyl group is added to the 
phenolic ring during preliminary ozonation and can be further ozonated to produce quinones on 
the same ring structure.  They also propose a structure with the phenolic ring broken, creating 
muconic EE2.  These theoretical suggestions of byproduct structures are the same as found in the 
Huber et al. (2004) and Zhang et al. (2006) studies; however, Zhang et al. determined the EE2 
ozonation byproducts using a GS/MS and Huber et al. used LC/MS/MS for positive 
identification of the actual byproducts.   
 
71 
 
There is no published research on the ozonation of DES available.  Since DES has a relatively 
strong estrogenic activity, it is important that the ozonation byproducts be identified. 
 
3.3 Other Removal Processes 
There are many additional techniques that have been evaluated for their effectiveness in 
removing endocrine disruptors from drinking water.  The following processes are not explored in 
this body of work, but it should be noted, they are equally as important as chlorination, 
chloramination and ozonation. 
 
3.3.1 Ultraviolet Irradiation 
Ultraviolet (UV) irradiation is an established technique for inactivating pathogens in wastewater.  
An advantage of UV over other some water treatment techniques is that no chemicals are added 
to the water and UV treatment does not lead to any known toxic byproducts (Mitch et al., 2002).  
UV has been used in treating photo-reactive chemicals and recent studies suggest that UV may 
be a possible treatment for EDCs (Rosenfeldt et al., 2004).  Previous studies of EDCs using 
conventional chlorination treatment have shown that estrogenic activity in some cases increases 
(Hu et al., 2002).  Whether this occurs with UV treatment is presently unknown.  The potential 
toxicity of E1 degradation products has been studied only after ozonation in which the phenol 
ring remained intact and the resulting estrogenic activity decreased (Huber et al., 2004).  
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3.3.2 Chlorine Dioxide Oxidation 
Research conducted by Lee et al. (2008) focused on the oxidation reaction of steroid estrogens 
and chlorine dioxide.  The second-order reaction rate constant found for ethinylestradiol and 
ClO2 was 1.83 x 105 M-1s-1 at a pH of 7 and a temperature of 20 oC.  This reaction is slower than 
that observed with EE2 and ozone; however, the reaction rate observed for chlorination of EE2 is 
slower compared to the ClO2 reaction (Deborde et al., 2004; Deborde et al., 2005). 
 
The initial byproducts formed in the reaction of EE2 with ClO2 were possibly due to the 
hydroxyl functional group from the phenolic moiety that donates electrons to the aromatic ring.  
Since the aromatic ring can accommodate additions of atoms with low electron density, the 
compounds containing a phenolic ring are highly reactive; therefore, the first reaction sites will 
be located on the aromatic ring. 
 
3.3.3 Sorptive Filtration 
Filtration systems have demonstrated varied abilities in EDC removal stemming from the 
differences in chemical properties of each compound.  The most promising type of filtration that 
has been studied to remove EDCs and PPCPs is riverbank filtration (Storck et al., 2010).  
Riverbank filtration is a low cost and low maintenance treatment technique that can be used as 
the first step to decontaminate surface waters.  The effectiveness of this treatment technique is 
based on the sorption capacity of the bank sediments, sorption and desorption behavior of 
contaminants, biodegradation ability and rate of flow through the sediments (Storck et al., 2010).   
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3.3.4 Coagulation 
Coagulation studies of estrogenic contaminants, including Westerhoff et al. (2005), show that 
low removal levels are achieved.  When a disinfectant is added to the coagulation treatment (e.g. 
chlorine or ozone, etc.), the removal rate levels increased with respect to the removal rate of the 
oxidant used for disinfection.  Since coagulation is a physical treatment of the contaminants, no 
daughter products will be formed.  With coagulation plus a disinfectant, the daughter products 
formed are only a result of the reaction between the disinfectant and the contaminant. 
 
3.3.5 Biological Treatment 
Biological treatment processes are not usually selected for drinking water treatment; however, 
research has been done on the biological removal of estrogenic compounds found in wastewaters 
and many daughter products have been identified.  Research pertaining to biological treatment 
applications for drinking water has increased due to the effectiveness and sustainability of the 
treatment systems, according to research conducted by Brown (2007).  Biological treatment of 
estrogenic compounds in drinking water will most likely increase due to the relatively high 
removal rates obtained from biological treatment of wastewater. 
 
3.4 Comparison of Treatment Effectiveness 
3.4.1 Experimental Design 
The treatment efficacies were compared (1) using the percent degradation of the parent EDC, (2) 
determining the number of byproducts produced from treatment with ring-structure intact, and 
(3) estimating the quantification of each byproduct produced.  Various contact time intervals, 
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including instantaneous, short and long term contact, were used to compare the treatments.  The 
initial byproducts formed from the reactions were found with near instantaneous contact (on the 
order of seconds).  To simulate the contact time used in drinking water treatment plants, a short 
contact time was selected for each type of disinfection, excluding chloramination because this 
treatment is typically used as a secondary disinfectant.  Long contact times of 48 hours were 
used to simulate the distribution system, with the exclusion of ozonation because the treatment is 
typically only used as a primary disinfectant.  Typical C·t values were chosen based on in-
practice values and for applicable comparisons of the differences in selecting disinfection types 
(Kawamura, 2000).  Table 3-1 provides a summary of the dose and duration for each treatment, 
with an initial EDC concentration of 10 ±0.1 µM for. 
 
Table 3-1: Summary of Treatment Types and Doses 
Treatment Type 
Instantaneous Contact Short Contact Long Contact* 
Dose Time Dose Time Dose Time 
Chlorination 2.5 mg/L 0-1 hr 
1.5 mg/L 
3.0 mg/L 
6.0 mg/L 
5 hrs 
1.5 mg/L 
3.0 mg/L 
6.0 mg/L 
48 hrs 
Chloramination 
(4mg-Cl2/mg-NH4Cl) 
2.5 mg/L Cl2 
0.6 mg/L NH4Cl 
0-1 hr 
1.5 mg/L 
3.0 mg/L 
6.0 mg/L 
5 hrs 
1.5 mg/L 
3.0 mg/L 
6.0 mg/L 
48 hrs 
Ozonation 
0.05 mg/L 
0.1 mg/L 
0.2 mg/L 
0.3 mg/L 
0.4 mg/L 
0.5 mg/L 
Rxn 
time 
1.5 mg/L 
2.0 mg/L 
3.0 mg/L 
6.0 mg/L 
Rxn 
time Not Applicable 
*Long and short contact for chloramination was preformed as pre-chlorination addition because 
this option is most widely used in treatment systems. 
 
The instantaneous ozone reaction consisted of doses with a molar ratio of less than or equal to 
one and the short contact time had doses with a larger than one molar ratio.  This ozonation 
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experimental design was implemented due to the rapid ozone reactions and the need to observe 
instantaneous byproducts. 
 
3.4.2 Analytical Methods 
An analytical method was optimized for EE2 and DES at both high and low concentrations.  The 
method was developed on the Waters Alliance 2695 Separation Module coupled to a Waters 
Quattro microTM API Quadrupole Mass Spectrometer using a Kromasil® C-18, 3.5 µm 4.6 x 150 
mm Column.  This method also utilized the Waters 2996 Photodiode Array Detector (PDA) 
attached to the Alliance prior to MS sample introduction.  A detailed discussion of methods used 
is provided in the Chapter 2 Analytical Methods. 
 
Byproduct identification utilized (1) the byproduct polarity relative to the parent compound, (2) 
the molecular weight and fragmentation pattern obtained from the mass spectrum, (3) the type of 
disinfection agent, (4) the isotope pattern observed on the mass spectrum, and (5) the absorbance 
of the byproduct at the local absorbance maximum of the parent compound.  
 
3.4.3 Research Objectives 
From the wide variety of pollutants considered as potential EDCs, the focal point of this research 
was on a select contaminant group due to their endocrine-disrupting potential and their presence 
in natural water, as reported in several previous studies (Fent et al., 2006; Huber et al., 2004; 
Richardson, 2002).  This research focused on 17β-ethinylestradiol and diethylstilbestrol.  
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Given the increasing problem of estrogenic EDC contamination in source waters, the purpose of 
this research was to determine which techniques were the most effective in removing EDCs and 
which introduced the least amount of harmful byproducts into the water supply system.  In order 
to determine which treatment was the most effective, each process was examined as to the 
percent degradation of the EDCs and the number of byproducts produced.  These experiments 
were conducted on an individual EDC basis due to the differences in side chain moieties 
associated with each EDC (Fent et al., 2006; Larson and Weber, 1994).  After degradation 
occurred, the byproducts were identified to determine if the ring structure from the parent 
compound remained intact.  Once the byproducts were identified, the treatment processes were 
compared using (1) the dose applied, (2) the number of byproducts formed and (3) the relative 
quantification of the treatment byproducts. 
 
3.5 Experimental Results for the Treatment of Synthetic EDCs 
Numerous studies have focused on the disinfection byproducts of ethinylestradiol; however, 
there have been few studies examining the reactions of diethylstilbestrol with disinfectants and 
the resulting byproducts.  The following sections present the results for the reactions of EE2 and 
DES with each of the disinfectants selected. 
 
3.5.1 Free Chlorination 
Procedures for the chlorination of EE2 and DES are provided in UMass Chlorination Standard 
Operating Procedures with specific experimental methods listed in Appendix B.  These batch 
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reactions were standardized to pH of 7.0 ± 0.1 and temperature 20 ± 1.0 oC, so that hypochlorous 
acid (HOCl) was the dominant free chlorine species for chlorination. 
 
Chlorination consisted of three experimental designs; instantaneous, short term and long term.  
Each experiment was conducted with excess Cl2 doses, as compared to the EDC initial 
concentration of 10 ± 0.1 µM.  For the instantaneous reactions, the free chlorine level used was 
2.5 mg/L.  Doses of 1.5 mg/L, 3.0 mg/L and 6.0 mg/L were used for the short and long term 
experiments.  The short term experiments had reaction times of 5 hrs and the long term 
experiments had a reaction time of 48 hrs.  Samples from the 5 and 48 hrs experiments were 
placed in 20 oC environment to maintain constant temperature throughout the reaction period. 
 
Kinetic models of the instantaneous reactions were not included in this study due to the emphasis 
on the byproduct identification.  Rate constant values are available from previous studies 
(Deborde et al., 2004).  Free chlorine was not measured during the instantaneous reactions due to 
the short reaction times and the duration of the titration process being longer than the reaction 
interval.  Free chlorine was measured in the short and long term experiments to determine the 
amount of chlorine residual remaining following the reactions.   
 
3.5.1.1 Chlorination of EE2 
Reactions 
For each chlorination reaction, it was observed that as EE2 was degraded, the total peak area of 
the byproducts increased.  The peak area was determined by manual integration of peaks isolated 
at 280 nm on the absorbance chromatogram.  As the free chlorine dose was increased, the EE2 
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concentration decreased in proportion to the amount of free chlorine added for the disinfection 
reaction.   
 
Figure 3-2 displays EE2 and total byproducts peak areas versus time, which resulted from the 
instantaneous chlorination of EE2.  Each experiment included initial concentrations of EE2 of 
10.0 ± 1.0 µM.   
 
Time
0 se
c
10 s
ec
20 s
ec
30 s
ec
40 s
ec
50 s
ec
60 s
ec
120
 
sec
300
 
sec
600
 
sec
180
0 se
c
360
0 se
c
Pe
ak
 
A
re
a
0
1000
2000
3000
4000
EE2 
Total BPs 
 
Figure 3-2:  Instantaneous Chlorination of Ethinylestradiol 
 
Results for each byproduct separated for individual time increments are presented in Appendix 
B.  The byproducts formed during the instantaneous reactions of EE2 were identical to those 
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observed in the short term and long term reactions.  The chlorine residuals found for the EE2 
long and short term chlorinations are also presented in Appendix B.   
 
Detection 
EE2 followed an exponential decay function, where the contaminant decreased significantly in 
early time intervals and with small changes in concentration after 2 min of reaction time.  At 
time 1800 sec, EE2 was not detected by LC/MS; therefore, it was assumed that nearly 100 % of 
the concentration was degraded.  The major byproducts formed from EE2 and Cl2 reaction were 
observed at 13, 14 and 19 min of elution time on the chromatogram based on absorbance at 280 
nm.  Two minor byproducts were found at 15 and 16 min on the chromatogram; however, there 
was insufficient information available to determine the precise indentity of the minor byproducts 
of EE2 and free chlorine. 
 
According to the the absorbance spectrum and the molar absorption coefficients for EE2, the 
maximum absorbance wavelength is at 280 nm.  The absorbance shows a characteristic phenolic, 
multiple-ring pattern of two local maxima between 190 nm and 400 nm.  It was therefore 
assumed that any byproducts detected having an absorbance at 280 nm and showing a similar 
absorbance pattern to EE2, would still have the parent ring structure intact.  Therefore, the PDA 
was used to isolate specific wavelengths on the total ion chromatogaphs.  Figure 3-3 shows the 
liquid chromatogram for isolated absorbance at 280 nm for the long term chlorination of EE2.  
Instantaneous and short term chlorination chromatograms are found in Appendix B.   
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Figure 3-3:  Long Term Chlorination of Ethinylestradiol LC Chromatogram with Isolated 280 
nm Absorbance 
 
Each peak on the UV280nm chromatogram was integrated to determine the associated areas.  The 
chlorination reactions produced five new byproducts (BPs), with the major BPs eluted at 13, 14 
and 19 min.  The change in peak areas versus time for the three major BPs and EE2 are shown in 
Figure 3-4 for the instantaneous chlorination reaction. 
 
81 
 
Time (sec)
0 1000 2000 3000 4000
Pe
ak
 
A
re
a
0
1000
2000
3000
4000
EE2 
BP 1 @13min 
BP 2 @14min 
BP 5 @19min 
 
Figure 3-4:  Formation of Major Byproducts from Chlorination of Ethinylestradiol 
 
As the reaction time progresses, EE2 follows an exponential decay function. The byproduct 1 at 
13 min was formed immediately after the chlorine dose was administered, then started to 
decrease after 600 sec of reaction.  The byproduct 2 at 14 min formed at a slower rate and 
yielded a lower concentration as compared to the byproduct 1 at 13 min; however, byproduct 2 
(14 min) was present within each instantaneous reaction time interval.  The byproduct 5 at 19 
min was formed immediately after the chlorine dose was introduced to the solution and was 
present in each instantaneous sample. 
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Identification 
The chlorination of EE2 was performed, finding three dominant byproducts and two minor 
byproducts with ring structures still intact.  The diode array spectrophotometer was used to 
determine if the byproducts absorbed at 280 nm, which is the relative maximum absorbance of 
EE2.  Figure 3-5 shows the carbon numbering format for EE2 to help in identification of carbon 
atoms within each moiety. 
 
 
Figure 3-5:  Ethinylestradiol 
 
The absorbance spectra for EE2 and the observed chlorination byproducts are shown in Figure 
3-6.  The byproducts 1 through, 4 found at 13, 14, 15 and 16 min, show the same two local 
absorbance maxima pattern as EE2 and elute prior to EE2 when using a mobile phase of 
methanol and water.  The byproduct 5 at 19 min contains only one local maximum in the 
corresponding absorbance spectrum and elutes after EE2.   
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Figure 3-6:  Absorbance of EE2 and Chlorination Byproducts 
 
Based on the retention times and corresponding polarity, mass spectra and absorbance at 280 nm, 
the major byproducts were identified for the chlorination of EE2 and presented in Table 3-2.  
The mass spectra for each byproduct are located in Appendix B. 
 
Table 3-2: Proposed Identification of EE2 and Chlorination Byproducts 
Analyte Retention Time (min) Identity 
EE2 17 min EE2 
Byproduct 1 13 min 2-chloro EE2 or 4-chloro EE2 (MW  331 m/z) 
Byproduct 2 14 min 2,4-dichloro EE2 (MW 365 m/z) 
Byproduct 3 15 min C20H23O3Cl MW 346 m/z 
Byproduct 4 16 min C20H21O2Cl3 MW 398 m/z 
Byproduct 5 19 min C20H22O3Cl2 MW 380 m/z 
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The proposed reactions between free chlorine and EE2 are shown in Figure 3-7.  The major 
byproducts, 4-chloro EE2, 2,4-chloro EE2 and MW 380, were immediately formed at the 
introduction of HOCl into a solution of EE2, attacking the phenolic moiety at the ortho 
position(s), with respect to the hydroxyl group at C3.  The minor byproducts could not be 
accurately identified on the mass spectra due to the lack of molecular ions.   
 
 
Figure 3-7:  Proposed Byproducts of HOCl and EE2 
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The byproducts found for the chlorination of EE2 are similar to those suggested by Moriyama et 
al. (2003) and Hu et al. (2003); however, the byproduct 5 that eluted at 19 min (MW 380 m/z) 
was not found in any study published on the chlorination of EE2.   
 
Other byproducts are formed from this reaction sequence but were not identified by this method 
due to their lack of absorbance at 280 nm and there were no other peaks located on the total ion 
chromatogram.  It was determined that other byproducts were formed due to the insufficient 
sums of EE2 and byproduct peaks areas in comparison to the initial EE2 peak area, assuming 
EE2 and the byproducts have the same molar absorption coefficients and produced the same 
mass spectral signal intensity. 
 
Relative Quantification 
The relative concentration of each chlorination byproduct was determined based on peak areas 
since calibration curves were unavailable for each byproduct.  For purposes of relative 
concentrations, it was assumed that the only byproducts formed during the reactions were those 
that absorbed at a wavelength of 280 nm.  The estimated quantification of each byproduct was 
based on the initial concentration of EE2 (10.0 ± 1.0 µM) and the molecular weights of each 
byproduct. 
 
For the instantaneous reactions with the chlorine dose of 2.5 mg/L, EE2 produced an 100 % 
degradation after a reaction time of 1800 sec.  For the short-term reactions, the dose of 1.5, 3.0 
and 6.0 mg/L Cl2 and EE2 showed an 82, 97 and 100 % degradation, respectively.  For the long-
term reactions, doses of 1.5, 3.0 and 6.0 mg/L Cl2 displayed an 86, 100 and 100 % EE2 
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degradation, respectively.  Figure 3-8 provides the relative concentrations of EE2 and its 
chlorination byproducts with the corresponding chlorine dose and reaction duration. 
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Figure 3-8:  Estimated Concentrations of EE2 and Chlorination Byproducts 
 
In order to compare the EE2 concentration and the estimated concentration of the byproducts, it 
was assumed that the byproducts had the same molar absorption at 280 nm as EE2. 
 
3.5.1.2 Chlorination of DES 
Reactions 
The byproducts formed during the instantaneous reactions of DES were identical to those 
observed in the short term and long term reactions.  As the dose was increased, the quantity of 
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the observed byproducts increased, but the number of byproducts remained constant.  The 
byproducts observed were not all immediately formed upon introduction of the chlorine dose, 
showing various reaction rates and production quantities.  Each experiment included initial 
concentrations of DES of 10.0 ± 1.0 µM and was treated with an excess molar ratio of Cl2.  Each 
reaction observed, showed a proportional increase in total byproducts with the degradation of 
DES.  Figure 3-9 shows DES and total byproducts results from the instantaneous chlorination of 
DES.   
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Figure 3-9:  Instantaneous Chlorination of Diethylstilbestrol 
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Chlorination of DES showed a 93 % degradation of the parent compound at 3600 sec reaction 
time.  Each byproduct separated for individual time increments is presented in Appendix B.  The 
chlorine residuals found for the DES long and short term chlorinations are also presented in 
Appendix B. 
 
Detection 
The chlorination of DES followed an expotenial decay function, where the contaminant 
decreased rapidly in early time intervals and with small changes in concentration after 120 sec of 
reaction time.  At time 3600 sec, DES was detected by LC/MS and it was estimated that 93 % of 
the initial concentration was degraded.  The major byproducts formed from DES and Cl2 reaction 
were observed at 13, 14 and 16 min on the chromatogram when the absorbance at 240 nm was 
isolated.  Two minor byproducts were found at 17 and 22 min on the chromatogram; however, 
there was insufficient information available to determine the precise indentity of these DES and 
free chlorine byproducts. 
 
According to the the absorbance spectrum for DES, the maximum absorbance wavelength is at 
240 nm.  The absorbance shows a characteristic phenolic pattern of one local maxima between 
190 nm and 400 nm.  It was therefore assumed that any byproducts detected having an 
absorbance at 240 nm and showing a similar absorbance pattern to DES, would still have the 
parent ring structure intact.  Therefore, the PDA was used to isolate specific wavelengths on the 
total ion chromatogaphs.  Figure 3-10 presents the liquid chromatogram with isolated absorbance 
at 240 nm for the long term chlorination.  Instantaneous and short term chlorination 
chromatograms are found in Appendix B.   
89 
 
 
Time (min)
6 8 10 12 14 16 18 20 22
A
bs
o
rb
an
ce
 
at
 
24
0 
n
m
0
2e+4
4e+4
6e+4
8e+4
1e+5
DES
1
2 3
5
4
 
Figure 3-10:  Diethylstilbestrol LC Chromatogram with Isolated 240 nm Absorbance 
 
From the isolated chromatogram, each peak was integrated to determine the associated areas.  
The chlorination reactions produced five byproducts, with the major byproducts 1,2 and 3 eluted 
at 13, 14 and 16 min, respectively.  The peak areas for the three major byproducts and DES are 
diplayed in Figure 3-11 for the instantaneous chlorination reaction. 
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Figure 3-11:  Formation of Major Byproducts from Chlorination of Diethylstilbestrol 
 
The reaction between DES and free chlorine did not produce immediate byproducts.  All major 
byproducts began formation after 30 sec of reaction time.  The byproducts 1 and 2, found at 13 
min and 14 min, reached their maximum concentrations at 600 sec and the byproduct 3 at 16 min 
reached its maximum quantity at 60 sec. 
 
Identification 
The chlorination of DES was performed, finding three dominant byproducts and two minor 
byproducts with ring structures still intact.  The diode array spectrophotometer was used to 
determine if the byproducts absorbed at 240 nm, which is the relative maximum absorbance of 
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DES.  Figure 3-12 shows the carbon numbering format for DES to help in identification of 
carbon atoms within each moiety.   
 
 
Figure 3-12:  Diethylstilbestrol 
 
The byproducts found at 13, 14 and 22 min show the same local maximum pattern as DES.  The 
byproducts at 16 and 17 min contain two local maximum in the corresponding absorbance 
spectrum.  Byproducts at 13, 14, 16 and 17 min elute prior to DES when using a mobile phase of 
methanol and water and BP 5 at 22 min elutes after DES.  The absorbance spectra for DES and 
the observed chlorination byproducts are shown in Figure 3-13. 
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Figure 3-13:  Absorbance of DES and Chlorination Byproducts 
 
Based on the retention times with corresponding polarity, mass spectra and absorbance at 240 
nm, the major byproducts were identified for the chlorination of DES and are presented in Table 
3-3. 
 
Table 3-3: Proposed Identification of DES and Chlorination Byproducts 
Analyte Retention Time (min) Identity 
DES 18 min DES 
Byproduct 1 13 min Tetrachloro DES  (MW 405 m/z) 
Byproduct 2 14 min Monochloro DES  (MW 302 m/z) 
Byproduct 3 16 min Trichloro DES  (MW 371 m/z) 
Byproduct 4 17 min Dichloro DES  (MW 336 m/z) 
Byproduct 5 22 min MW 265 m/z 
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The proposed reactions between free chlorine and DES are shown in Figure 3-14.  There was 
insufficient information available on byproduct 5 to determine a chemical structure. 
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Figure 3-14:  Proposed Byproducts of HOCl and DES 
 
The major byproducts, monochloro DES, dichloro DES and tetrachloro DES, were formed 
approximately 20 sec after the introduction of HOCl into a solution of DES, attacking the both 
phenolic moieties at the ortho position(s), with respect to the hydroxyl groups at C3 and C16.  
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The minor byproducts could not be accurately identified due to the lack of molecular ions on the 
mass spectra.  The mass spectra for DES and each byproduct are located in Appendix B.  
 
Relative Quantification 
The relative concentration of each chlorination byproduct was determined based on peak areas 
since calibration curves were unavailable for the respective byproducts.  For purposes of relative 
concentrations, it was assumed that the only byproducts formed during the reactions were those 
that absorbed at a wavelength of 240 nm.  The estimated quantification of each byproduct was 
based on the initial concentration of DES (10.0 ± 1.0 µM) and the molecular weights found for 
each byproduct.  In order to compare the DES concentration and the estimated concentration of 
the byproducts, it was assumed that the byproducts had the same molar absorption at 240 nm as 
DES. 
 
Figure 3-15 provides the relative concentration of chlorination byproducts for both the long and 
short term reactions.  The instantaneous chlorination reactions demonstrated a DES degradation 
of 93 % at 3600 sec with a dose of 2.5 mg/L Cl2.  For the short-term reactions, the dose included 
1.5, 3.0 and 6.0 mg/L Cl2 and DES displayed a percent degradation of 45, 95 and 97 %, 
respectively.  For the long-term reactions, the dose also included 1.5, 3.0 and 6.0 mg/L Cl2 and 
DES showed a 74, 98 and 100 % degradation, respectively.   
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Figure 3-15:  Estimated Concentrations of DES and Chlorination Byproducts 
 
3.5.2 Chloramination 
Chloramination procedures followed the UMass Standard Operating Procedures.  The 
chloramination disinfection treatment included pre-ammoniation, pre-chlorination, simultaneous 
addition of ammonia and chlorine solutions and pre-mixed chloramination.  The long (48 hrs) 
and short (5 hrs) contact times for chloramination were preformed using pre-chlorination then 
ammonia addition as is customary in treatment systems. 
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3.5.2.1 Chloramination of EE2 
Reactions 
As the dose was increased, the quantity of the byproducts observed for each chloramination 
reaction remained constant and the number of byproducts was constant within each method.    
Each experiment included initial concentrations of EE2 of 10.0 ± 1.0 µM and was treated with a 
molar ratio of Cl2:N of 4 and a Cl2 concentration of 2.5 mg/L.  
 
For the pre-ammoniation chloramination reaction with EE2, there was one byproduct formed.  
The simultaneous addition of chlorine and ammonia created two byproducts from the resulting 
reaction.  With the pre-formed chloramines solution, there were no byproducts that formed 
during the reaction with EE2. 
 
In the pre-chlorination instantaneous reactions, there were two byproducts produced that were 
the same as those produced in the short-term reaction.  The byproducts formed during the pre-
chlorination chloramination instantaneous reactions of EE2 were identical to those observed in 
the pre-chlorination long term reactions.  As observed in each type of chloramination reaction 
with EE2, the addition of ammonia to the solution affectively quenched the free chlorine present 
and significantly decreased the reaction rates. 
 
Each byproduct separated for individual time increments is presented in Appendix B, along with 
the total byproducts and EE2 peak areas for the instantaneous chloramination reactions.  The 
chlorine residuals found for the EE2 long and short term chloraminations are also available in 
Appendix B. 
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Detection 
EE2 showed minute degradation rates associated with each chloramination method.  The 
byproduct formed from EE2 and pre-ammoniation chloramination reactions was observed at 13 
min elution time on the chromatogram based on absorbance at 280 nm was isolated.  Two 
byproducts were found during the pre-chlorination and simultaneous addition instantaneous 
reactions and were observed at 13 and 19 min on the chromatograms when the absorbance at 280 
nm was isolated.  The pre-formed chloramine chloramination chromatogram did not produce 
byproducts that absorbed at 280 nm.   
 
For the short-term, pre-chlorination chloramination reactions, there were two byproducts formed 
at 13 and 19 min.  The same byproducts were formed, eluting at 13 and 19 min, as a result of 
long-term, pre-chlorination chloramination reactions. 
 
Figure 3-16 displays the liquid chromatograms for chloramination reactions with isolated 
absorbance at 280 nm.   
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Figure 3-16:  Chloramination of Ethinylestradiol; LC Chromatograms Based on Absorbance at 
280 nm 
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Table 3-4 provides the percent degradation and number of byproducts formed for each respective 
chloramination type and chloramine dose. 
 
Table 3-4: Chloramination of EE2 
Chloramination Type Dose (Cl2/N of 4) 
% Degradation 
of EE2 
Number of 
Byproducts* 
Pre-Ammoniation (3600 sec) 2.5 mg/L Cl2 9 % 1 
Pre-Chlorination (3600 sec) 2.5 mg/L Cl2 27 % 2 
Simultaneous Addition (3600 sec) 2.5 mg/L Cl2 9.5 % 2 
Pre-Mixed Chloramination (3600 sec) 2.5 mg/L Cl2 3 % 0 
Short Term Pre-Chlorination 
1.5 mg/L Cl2 
3.0 mg/L Cl2 
6.0 mg/L Cl2 
19 % 
35 % 
52 % 
2 
2 
2 
Long Term Pre-Chlorination 
1.5 mg/L Cl2 
3.0 mg/L Cl2 
6.0 mg/L Cl2 
28 % 
50.5 % 
61.5 % 
2 
2 
2 
*Byproducts produced from treatment with substantial absorbance at 280 nm 
 
Identification 
The chloramination of EE2 was performed, finding two dominant byproducts with ring 
structures intact.  The diode array spectrophotometer was used to determine if the byproducts 
absorbed at 280 nm, which was the relative maximum absorbance of EE2.  Figure 3-5 shows the 
carbon numbering format for EE2 to help in identification of carbon atoms within each moiety. 
 
The byproduct 1 found at 13 min conforms to the same two local maxima pattern as EE2 and 
elutes prior to EE2 when using a mobile phase of methanol and water.  The byproduct 2 at 19 
min contains only one local maximum in the corresponding absorbance spectrum and elutes after 
EE2.  The absorbance spectra for EE2 and the observed chloramination byproducts are presented 
in Figure 3-17. 
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Figure 3-17:  Absorbance of EE2 and Chloramination Byproducts 
 
Based on the retention times and corresponding polarity, mass spectra and absorbance at 280 nm, 
the major byproducts were identified for the chloramination of EE2 and are presented in Table 
3-5.   
 
Table 3-5: Proposed Identification of EE2 and Chloramination Byproducts 
Analyte Retention Time (min) Identity 
EE2 17 min Ethinylestradiol 
Byproduct 1 13 min C20H21O2Cl3 MW 398 m/z 
Byproduct 2 19 min C20H22O3Cl2 MW 380 m/z 
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The major byproducts, MW 398 m/z and MW 379 m/z, were formed during the long-term 
chloraminations with 3.0 and 6.0 mg/L chloramines doses.  The byproduct 1 at 13 min (MW 398 
m/z) was created by the free-chlorine attacking the phenolic moiety at the ortho positions, with 
respect to the hydroxyl group at C3, and C18.  Free-chlorine was available for the reaction with 
EE2 due to the pre-chlorination step within the chloramination type.   
 
The byproduct 2 at 19 min (MW 379 m/z) was created by the free-chlorine attacking the 
phenolic moiety at the ortho position (C4 or C2) and losing a hydrogen atom to produce a 
carbonyl group replacing the hydroxyl group at C3.  The five carbon ring opened to form a 
carboxylic acid group on C17.  An addition of a chlorine atom to C18 resulted in the change of 
the triple bond to a double bond from C18 to C19.   
 
The mass spectra for EE2 and each chloramination byproduct formed are found in Appendix B.  
The proposed reactions between chloramines and EE2 are shown in Figure 3-18. 
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Figure 3-18:  Proposed Byproducts of NH2Cl and EE2 
 
The chloramination byproducts generally conform to the same structures as that of the 
chlorination byproducts unless amine reactive functional groups are present (Bull and Kopfler, 
1991).  Since EE2 does not contain moieties that are reactive with amines but are highly reactive 
with free chlorine, the byproducts that formed as a result of each type of chloramination were the 
same as the chlorination byproducts.  The major differences between the chlorination byproducts 
and the chloramination byproducts for EE2 reactions were the slower reaction rates and 
decreased quantity of byproduct formation for the chloramination reactions. 
 
Relative Quantification 
The relative concentration of each chloramination byproduct was determined based on peak 
areas since authentic standards were unavailable for the proposed byproduct.  For purposes of 
relative concentrations, it was assumed that the only byproducts formed during the reactions 
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were those that absorbed at a wavelength of 280 nm.  The estimated quantification of each 
byproduct was based on the initial concentration of EE2 (10.0 ± 1.0 µM) and the molecular 
weights determined for each byproduct. 
 
Figure 3-19 provides the relative concentrations of EE2 and its chloramination byproducts with 
respect to the dose and reaction time. 
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Figure 3-19:  Estimated Concentrations of EE2 and Chloramination Byproducts 
 
The instantaneous chloramination reactions displayed an EE2 degradation of 9, 27, 9.5 and 3 % 
at 3600 sec with a dose of 2.5 mg/L Cl2 and a Cl2:N ratio of 4, for pre-ammoniation, pre-
chlorination, simultaneous addition and pre-formed addition respectively.  For the short-term 
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pre-chlorination reactions, the dose included 1.5, 3.0 and 6.0 mg/L Cl2 with a Cl2:N ratio of 4 
and EE2 showed a percent degradation of 19, 35 and 52 %, respectively.  For the long-term pre-
chlorination reactions, the dose also included 1.5, 3.0 and 6.0 mg/L Cl2 with and a Cl2:N ratio of 
4 and EE2 demonstrated a 28, 50.5 and 61.5 % degradation, respectively. 
 
3.5.2.2 Chloramination of DES 
Reactions 
As the dose was increased, the quantity of the byproducts observed for each chloramination 
reaction remained constant and the number of byproducts stayed constant within each method.    
Each experiment included initial concentrations of DES of 10.0 ± 1.0 µM and was treated with a 
molar ratio of Cl2:N of 4 and a Cl2 concentration of 2.5 mg/L.  
 
For the pre-ammoniation, the simultaneous addition of chlorine and ammonia and the pre-formed 
chloramines solution reactions, no byproducts formed during the reactions with DES.  In the pre-
chlorination instantaneous reactions, there were also no byproducts produced.  The byproducts 
formed during the pre-chlorination chloramination short term reactions of DES were identical to 
those observed in the pre-chlorination long term reactions; however, there was an additional 
byproduct detected for the long-term reaction.  As observed in each type of chloramination 
reaction with DES, the addition of ammonia to the solution affectively quenched the free 
chlorine present and significantly decreased the reaction rates. 
 
Each byproduct separated for individual time increments is presented in Appendix B, along with 
the total byproducts and DES peak areas for the instantaneous chloramination reactions.  The 
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chlorine residuals found for the DES long and short term chloraminations are also presented in 
Appendix B. 
 
Detection 
DES showed small degradation rates associated with each chloramination method.  The 
byproducts formed from DES and the chloramination reactions were not observed on the 
chromatogram when the absorbance at 280 nm was isolated.  For the short-term, pre-chlorination 
chloramination reactions, there were two byproducts formed with retention times of 14 and 17 
min.  Three byproducts were formed with retention times of 14, 15 and 17 min as a result of 
long-term, pre-chlorination chloramination reactions. 
 
Figure 3-20 shows the liquid chromatograms for chloramination reactions with isolated 
absorbance at 240 nm.   
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Figure 3-20:  Chloramination of Diethylstilbestrol; LC Chromatograms Based on Absorbance at 
240 nm 
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Table 3-6 provides the resulting percent degradation and number of byproducts formed for each 
respective chloramination type and chloramine dose. 
 
Table 3-6: Chloramination of DES 
Chloramination Type Dose (Cl2/N of 4) 
% Degradation 
of DES 
Number of 
Byproducts* 
Pre-Ammoniation 2.5 mg/L Cl2 8 % 0 
Pre-Chlorination 2.5 mg/L Cl2 18 % 0 
Simultaneous Addition 2.5 mg/L Cl2 7 % 0 
Pre-Mixed Chloramination 2.5 mg/L Cl2 1 % 0 
Short Term Pre-Chlorination 
1.5 mg/L Cl2 
3.0 mg/L Cl2 
6.0 mg/L Cl2 
7 % 
16 % 
37 % 
1 
2 
2 
Long Term Pre-Chlorination 
1.5 mg/L Cl2 
3.0 mg/L Cl2 
6.0 mg/L Cl2 
20.5 % 
33 % 
55 % 
1 
3 
3 
*Byproducts produced from treatment with substantial absorbance at 240 nm.  
 
The reaction between DES and chloramines did not produce immediate byproducts.  Major 
byproduct formation began during the short term reaction time.  The three major byproducts 
resulting from the long and short term chloraminations remained constant during the 3.0 and 6.0 
mg/L dose.  At the 1.5 mg/L dose, however, only one byproduct was produced, which was the 
same compound for both short and long reaction times. 
 
Identification 
The chloramination of DES was performed, finding three dominant byproducts with ring 
structures still intact.  The diode array spectrophotometer was used to determine whether the 
byproducts absorbed at 240 nm, which is the relative maximum absorbance of DES.  Figure 3-12 
presents the carbon numbering format for DES to assist in identification of carbon atoms within 
each moiety. 
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The byproducts found at 14, 15 and 17 min show the same local maximum pattern as DES.  The 
chloramination byproducts at 14, 15 and 17 min elute prior to DES when using a mobile phase of 
methanol and water.  The absorbance spectra for DES and the observed chlorination byproducts 
are shown in Figure 3-21. 
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Figure 3-21:  Absorbance of DES and Chloramination Byproducts 
 
Based on the retention times and corresponding polarity, mass spectra and absorbance at 240 nm, 
the major byproducts were identified for the chloramination of DES and presented in Table 3-7.   
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Table 3-7: Proposed Identification of DES and Chloramination Byproducts 
Analyte Retention Time (min) Identity 
DES 18 min Diethylstilbestrol 
Byproduct 1 14 min Dichloro DES MW 339 m/z 
Byproduct 2 15 min Monochloro DES MW 302 m/z 
Byproduct 3 17 min Monochloro DES MW 302 m/z 
 
Three major byproducts, monochloro DES, dichloro DES and trichloro DES, were formed 
during the long-term pre-chlorination chloramination of DES.  These byproduct formations were 
the result of free-chlorine attacking both phenolic moieties at the ortho position(s), with respect 
to the hydroxyl groups at C3 and C16.   
 
The mass spectra for DES and each chloramination byproduct formed are located in Appendix B.  
The proposed reactions between chloramines and DES are shown in Figure 3-22. 
 
 
Figure 3-22:  Proposed Byproducts of NH2Cl and DES 
110 
 
 
As seen with the chloramination of EE2, the byproducts of DES chloramination were similar to 
the chlorination byproducts; however, the chlorination reactions produced fewer numbers and 
lesser quantities of byproducts.  The byproducts which were formed in the chloramination of 
DES were the result of free chlorine reacting with DES instead of chloramines reacting with 
DES. 
 
Due to the apparent polarity of the byproduct 1 at 14 min, as observed on the chromatogram, and 
the molecular weight, as identified on the mass spectrum, this byproduct was identified as 
dichloro DES, with both chlorine atoms on the same phenolic moiety, which produced a 
relatively high polarity.  The byproducts that eluted at 15 and 17 min showed identical molecular 
weights and fragmentation patterns; therefore, it was assumed that both byproducts were 
monochloro DES with the chlorine atom attaching at different positions on the parent compound. 
 
Relative Quantification 
The relative concentration of each chloramination byproduct was determined based on peak 
areas since calibration curves were unavailable for individual byproducts.  For purposes of 
relative concentrations, it was assumed that the only byproducts formed during the reactions 
were those that absorbed at a wavelength of 240 nm.  The estimated quantification of each 
byproduct was based on the initial concentration of DES (10.0 ± 1.0 µM) and the molecular 
weights found for each byproduct.  Figure 3-23 presents DES and its chloramination byproducts 
with respect to dose and reaction time. 
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Figure 3-23:  Estimated Concentrations of DES and Chloramination Byproducts 
 
The instantaneous chloramination reactions produced a DES degradation of 8, 18, 7 and 1 % at 
3600 sec with a dose of 2.5 mg/L Cl2 and a Cl2:N ratio of 4, for pre-ammoniation, pre-
chlorination, simultaneous addition and pre-formed addition respectively.  For the short-term 
reactions, the dose included 1.5, 3.0 and 6.0 mg/L Cl2 with a Cl2:N ratio of 4 and DES 
demonstrated a percent degradation of 7, 16 and 37 %, respectively.  For the long-term reactions, 
the dose also included 1.5, 3.0 and 6.0 mg/L Cl2 with and a Cl2:N ratio of 4 and DES established 
a 20.5, 33 and 55% degradation, respectively. 
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3.5.3 Ozonation 
Ozonation procedures followed the UMass Standard Operating Procedures, with specific 
experimental procedures presented in Appendix B.  Ozone concentrations were determined using 
absorbance of O3 at 258 nm and the molar absorption coefficient (ε258nm = 3000 M-1cm-1).  Due 
to the possible functional groups added to the byproducts, both ESI negative and ESI positive 
modes were implemented on the LC/MS, which provided the ability to attach corresponding 
charges in the different ionization modes.  The data for the different ESI modes are presented 
separately due to the differences in signal intensity within the different modes and the resulting 
impact on the relative byproduct formation potentials.  When the relative concentration of the 
byproducts are presented, only byproducts that absorb at the corresponding parent compound 
local maximum (280 nm or 240 nm) were included, which denotes the intact ring structure.  
Since the relative concentrations are based on peak areas and the original parent concentration, 
both positive and negative ionization modes data were separated to determine the relative 
concentrations for each byproduct with the ring structure intact. 
 
The instantaneous ozonation reactions were not based on time intervals but were selected on a 
molar ratio of ≤ 1 as compared to the respective EDC contaminant.  With an initial concentration 
of 10 ± 0.1 µM, the concentrations of O3 selected were as follows: 1, 2, 4, 6, 8 and 10 µM.  The 
short term ozonation reactions were also based on concentration, which were selected on molar 
ratios of ≥1 as compared to the respective EDC contaminant.  The short term ozonation 
concentrations were 1.5, 2.0, 3.0 and 6.0 mg/L O3. 
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Ozone reaction durations vary with the amount of ozone added to a solution and the amount of 
contaminant in the solution; therefore, it was assumed that the ozonation reaction would be 
complete after 10 min of reaction time.  This significantly greater period of time, as compared to 
the reaction rates determined for the ozonation of EE2, was selected to meet the assumption that 
the reaction between the parent and/or the byproduct was complete with regards to the ozone 
reaction (Deborde et al., 2005). 
 
Ice baths were used to increase the concentration of ozone in stock solutions.  This decrease in 
temperature to approximately 5 oC, interfered with the absorbance measurements, due to the 
condensation forming on the cuvette, which in turn produced artificially high absorbance values.  
The lower temperature of the ozone stock solution in comparison to the sample solution may also 
have decreased the reaction rates. 
 
3.5.3.1 Ozonation of EE2 
Reactions 
Figure 3-24 and Figure 3-26 show EE2 and total byproducts peak areas versus ozone dose, which 
resulted from the instantaneous and short term ozonation of EE2 for ESI negative, respectively.  
Figure 3-25 and Figure 3-27 show EE2 and total byproducts peak areas versus ozone dose, which 
resulted from the instantaneous and short term ozonation of EE2 for ESI positive, respectively.  
Each experiment included initial concentrations of EE2 of 10.0 ± 1.0 µM.   
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Figure 3-24:  Instantaneous Ozonation of EE2 (ESI Negative) 
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Figure 3-25:  Instantaneous Ozonation of EE2 (ESI Positive) 
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Figure 3-26:  Short Term Ozonation of EE2 (ESI Negative) 
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Figure 3-27:  Short Term Ozonation of EE2 (ESI Positive) 
 
116 
 
For each ozonation reaction, it was observed that as EE2 was degraded, the total peak area of the 
byproducts increased.  As the ozone dose was increased, the EE2 concentration also decreased in 
similar proportions to the O3 added for the disinfection reaction.  Results for each byproduct 
separated for individual ozone doses is presented in Appendix B for both the instantaneous and 
short term ozonation of EE2. 
 
Detection 
EE2 displayed a linear decay function for both the instantaneous and short term ozonation 
reactions.  The byproducts formed from EE2 and instantaneous O3 reaction were observed at 10 
and 13 min on the chromatogram when the absorbance at 280 nm was isolated in ESI negative 
mode.  At an O3 dose of 10 µM, 23 % of the EE2 concentration degraded.   
 
Figure 3-28 and Figure 3-29 show the liquid chromatograms for the intantaneous ozonation of 
EE2 with isolated absorbance at 280 nm for both ESI negative and positive modes.   
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Figure 3-28:  ESI Negative Isolated Absorbance at 280 nm Chromatogram of EE2 Instantaneous 
Ozonation 
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Figure 3-29:  ESI Positive Isolated Absorbance at 280 nm Chromatogram of EE2 Instantaneous 
Ozonation 
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The byproducts formed from EE2 and short term O3 reaction were observed at retention times of 
6, 9, 10, 13, 15 and 19 min when the absorbance at 280 nm was isolated in the ESI negative 
mode.  At an O3 dose of 6 mg/L, 97 % of the EE2 concentration was degraded. 
 
Figure 3-30 and Figure 3-31 show the liquid chromatograms for the short term ozonation of EE2 
with isolated absorbance at 280 nm in the ESI negative and positive mode, respectively.  From 
the isolated chromatograms, each peak was integrated to determine the associated areas.   
 
Time (min)
6 8 10 12 14 16 18 20 22
A
bs
o
ra
n
ce
 
at
 
28
0n
m
0
2000
4000
6000
8000
10000
EE2
1
2
3
4
5
 
Figure 3-30:  ESI Negative Chromatogram of EE2 Short Term Ozonation with Isolated 
Absorbance at 280 nm 
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Figure 3-31:  ESI Positive Chromatogram of EE2 Short Term Ozonation with Isolated 
Absorbance at 280 nm 
 
The peak areas for the major byproducts and EE2 versus ozone dose are shown in Figure 3-32 
and Figure 3-34 for the instantaneous ozonation reaction and for the short term ozonation 
reaction in ESI negative mode.  Figure 3-33 and Figure 3-35 display the byproduct formation in 
ESI positive mode for the instantaneous and short term reaction, respectively. 
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Figure 3-32:  Formation of ESI Negative Major Byproducts from Instantaneous Ozonation of 
Ethinylestradiol 
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Figure 3-33:  Formation of ESI Positive Major Byproducts from Instantaneous Ozonation of 
Ethinylestradiol 
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Figure 3-34:  Formation of ESI Negative Major Byproducts from Short Term Ozonation of 
Ethinylestradiol 
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Figure 3-35:  Formation of ESI Positive Major Byproducts from Short Term Ozonation of 
Ethinylestradiol 
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As the ozone dose increased, EE2 followed a linear decay function.  The byproduct at 9 min was 
formed immediately after the lowest ozone dose was administered, then started to decrease after 
the ozone dose was increased.  Byproducts found at 10 and 19 min followed a linear growth 
function.  The byproduct at 12 minutes increased in quantity until the 3.0 mg/L dose was 
administered, then a drop in byproduct at 12 min was observed.  The byproduct at 15 min formed 
at a slower rate and a lower yield as compared to the other byproducts.   
 
Identification 
The byproducts at 15 and 19 min contain two local maximum in the corresponding absorbance 
spectrum, following the EE2 pattern.  The byproducts found at 9, 10 and 13 min show a single 
local maximum pattern.  Byproducts at 9, 10, 13 and 15 min eluted prior to EE2 when using a 
mobile phase of methanol and water and BP at 19 min eluted after EE2.  The absorbance spectra 
for EE2 and the observed ozonation byproducts are presented in Figure 3-36, Figure 3-37 and 
Figure 3-38. 
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Figure 3-36:  Absorbance of EE2 and ESI Negative Ozonation Byproducts 
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Figure 3-37:  Absorbance of EE2 and ESI Positive Ozonation Byproducts 6 through 10 
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Figure 3-38:  Absorbance of EE2 and ESI Positive Ozonation Byproducts 11 through 16 
 
Based on the retention times and corresponding polarity, mass spectra and absorbance at 280 nm, 
the major byproducts were identified for the ozonation of EE2 and presented in Table 3-8 and 
Table 3-9.   
 
Table 3-8: Proposed Identification of EE2 and ESI Negative Ozonation Byproducts 
Analyte Retention Time (min) Identity 
EE2 17 min Ethinylestradiol 
Byproduct 1 9 min C20H24O3 MW 312 m/z 
Byproduct 2 10 min C20H24O3 MW 312 m/z 
Byproduct 3 13 min C20H22O4 MW 326 m/z 
Byproduct 4 15 min MW 339 m/z 
Byproduct 5 19 min C20H22O3Cl2  MW 379 m/z 
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Table 3-9: Proposed Identification of EE2 and ESI Positive Ozonation Byproducts 
Analyte Retention Time (min) Identity 
EE2 17 min Ethinylestradiol 
Byproduct 6 7 min C20H22O6  MW 358 m/z 
Byproduct 7 8 min C20H27O8  MW 398 m/z 
Byproduct 8 9 min C20H22O5  MW 342 m/z 
Byproduct 9 10 min C20H16O7 MW 368 m/z 
Byproduct 10 12 min C20H24O4  MW 328 m/z 
Byproduct 11 13 min C20H18O7  MW 370 m/z 
Byproduct 12 14 min C20H26O6  MW 362 m/z 
Byproduct 13 15 min C20H23O2Cl3  MW 400 m/z 
Byproduct 14 16 min MW 353 m/z 
Byproduct 15 16.8 min MW 353 m/z 
Byproduct 16 19 min C20H22O2Cl4  MW 435 m/z 
 
Sixteen byproducts were formed during the ozonation of EE2; five of these byproducts were 
detected using ESI negative and eleven of the byproducts were detected using ESI positive.  
These byproduct formations were the result of oxygen radicals or molecular ozone attacking the 
phenolic moiety at the ortho position(s), with respect to the hydroxyl group at C3.  Oxygen 
radicals may also have attacked the five carbon ring and breaking the bond between C16 and 
C17, creating a carboxylic acid group on C17.  Based on the isotope pattern for byproducts 5, 13 
and 16, chlorinated ozonation byproducts were produced as a result of dilute levels of HCl (10-4 
M) in the ozone stock solution, which aided in the increase of the ozone stock concentration.  
Byproducts 4, 14 and 15 were not identified due to the insufficient fragmentation information on 
the mass spectra. 
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The mass spectra for EE2 and each ozonation byproduct formed are located in Appendix B.  The 
proposed reactions between ozone and EE2 are shown in Figure 3-39 and Figure 3-40, where 
solid arrows indicate identified byproducts and dashed arrows signify potential byproducts. 
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Figure 3-39:  Proposed ESI Negative Byproducts from the O3 and EE2 Reaction 
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Figure 3-40:  Proposed ESI Positive Byproducts from the O3 and EE2 Reaction 
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The byproducts found in ESI negative are similar to those suggested by Lee et al (2008) and 
Zhang et al. (2006); however  many more possible byproducts were determined due to second 
reaction step or ozonation of preliminary byproducts that were detected. 
 
The chlorinated ozonation byproducts are shown in Figure 3-41. 
 
 
Figure 3-41:  Proposed Chlorinated Ozonation Byproducts from the EE2 Reaction 
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Relative Quantification 
Since the ozone stock solution did not reach a highly concentrated solution, even when using an 
ice bath, the short term ozonation doses were relatively high compared to the other treatment 
doses.  This larger dose volume resulted in a dilution of the sample solutions and an artificial 
decrease in EE2 concentration for the short term reactions. 
 
The relative concentration of each ozonation byproduct was determined based on peak areas 
since authentic standards were unavailable for each byproduct.  For purposes of relative 
concentrations, it was assumed that the only byproducts formed during the reactions were those 
that absorbed at a wavelength of 280 nm.  The estimated quantification of each byproduct was 
based on the initial concentration of EE2 (10.0 ± 1.0 µM) and the molecular weights found for 
each byproduct.  Figure 3-42 (ESI negative) and Figure 3-43 (ESI Positive) provide EE2 and its 
ozonation byproducts with respect to dose. 
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Figure 3-42:  Estimated Concentrations of EE2 Short Term Ozonation Byproducts  
(ESI Negative) 
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Figure 3-43:  Estimated Concentrations of EE2 Short Term Ozonation Byproducts  
(ESI Positive) 
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The instantaneous ozonation reactions showed an EE2 degradation of 23 % for 0.5 mg/L O3 
instantaneous dose.  For the short-term reactions with a dose of 6.0 mg/L O3, EE2 provided a 
degradation of 97 % according to the ESI negative peak areas.   
 
3.5.3.2 Ozonation of DES 
Reactions 
Figure 3-44 and Figure 3-50 show DES and total byproducts peak areas versus ozone dose, 
which resulted from the instantaneous and short term ozonation of DES in ESI negative, 
respectively.  Figure 3-45 and Figure 3-47 provide the peak areas for the ESI positive byproducts 
of DES ozonation.  Each experiment included initial concentrations of DES of 10.0 ± 1.0 µM.   
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Figure 3-44:  Instantaneous Ozonation of DES (ESI Negative) 
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Figure 3-45:  Instantaneous Ozonation of DES (ESI Positive) 
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Figure 3-46:  Short Term Ozonation of DES (ESI Negative) 
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Figure 3-47:  Short Term Ozonation of DES (ESI Positive) 
 
For each ozonation reaction, it was observed that as DES was degraded, the total peak area of the 
byproducts increased.  As the ozone dose was increased, the DES concentration also decreased in 
similar proportions to the O3 added for the disinfection reaction.  Results for each byproduct 
separated for individual ozone dose is presented in Appendix B for both the instantaneous and 
short term ozonation of DES. 
 
Detection 
DES followed a curvalinear decay function for both the instantaneous and short term ozonation 
reactions.  The byproducts formed from DES and the instantaneous O3 reactions were observed 
at 8, 9, 11, 12, 13, 14, 15 and 19 min on the chromatogram when the absorbance at 240 nm was 
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isolated.  At an O3 dose of 10 µM, 35 % of the DES concentration was degraded.  At an O3 dose 
of 6 mg/L, 100 % of the DES degraded. 
 
Figure 3-48 and Figure 3-49 show the liquid chromatograms for the intantaneous ozonation of 
DES with isolated absorbance at 240 nm in ESI negative and positive, respectively.   
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Figure 3-48:  Isolated Absorbance at 240 nm Chromatogram of DES Instantaneous Ozonation 
(ESI Negative) 
 
The byproducts formed from DES and instantaneous O3 reaction were observed at 7, 8, 9, 10, 12, 
13, 14, 15, 17, 19 and 21 min on the ESI positive chromatogram when the absorbance at 240 nm 
was isolated.   
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Figure 3-49:  Isolated Absorbance at 240 nm Chromatogram of DES Instantaneous Ozonation 
(ESI Positive) 
 
The byproducts formed from DES and short term O3 reaction were observed at 8, 9, 11, 12, 13, 
14, 16 and 19 min on the ESI negative chromatogram when the absorbance at 240 nm was 
isolated.  With an O3 dose of 6.0 mg/L, DES was not detected by LC/MS; therefore, it was 
determined that 100 % of the concentration was degraded.  The byproducts formed from DES 
and short term O3 reaction were observed at 7, 8, 9, 10, 12, 13, 14, 15, 17, 19 and 21 min on the 
ESI positive chromatogram when the absorbance at 240 nm was isolated.   
 
Figure 3-50 and Figure 3-51 show the liquid chromatograms for the short term ozonation of DES 
with isolated absorbance at 240 nm in ESI negative and positive, respectively.  From the isolated 
chromatograms, each peak was integrated to determine the associated areas.   
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Figure 3-50:  Chromatogram of DES Short Term Ozonation with Isolated Absorbance at 240 nm 
(ESI Negative) 
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Figure 3-51:  Chromatogram of DES Short Term Ozonation with Isolated Absorbance at 240 nm 
(ESI Positive) 
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The peak areas for the major byproducts and DES versus ozone dose are shown in for the Figure 
3-52, Figure 3-53, Figure 3-54 and Figure 3-55 instantaneous ozonation reaction and for the 
short term ozonation reaction. 
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Figure 3-52:  Formation of Major Byproducts from Instantaneous Ozonation of 
Diethylstilbestrol (ESI Negative) 
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Figure 3-53:  Formation of Major Byproducts from Instantaneous Ozonation of 
Diethylstilbestrol (ESI Positive) 
 
Ozone Dose (mg/L)
1 2 3 4 5 6 7
B
yp
ro
du
ct
s 
Pe
ak
 
A
re
a
0
500
1000
1500
2000
2500
3000
D
ES
 
Pe
ak
 
A
re
a
0
1000
2000
3000
4000
5000
6000
BP@8min 
BP@9min 
BP@11min 
BP@12min 
BP@13min 
BP@14min 
BP@16min 
BP@19min 
DES 
 
Figure 3-54:  Formation of Major Byproducts from Short Term Ozonation of Diethylstilbestrol 
(ESI Negative) 
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Figure 3-55:  Formation of Major Byproducts from Short Term Ozonation of Diethylstilbestrol 
(ESI Positive) 
 
Identification 
The byproducts found at 11, 12, 13, 14, 16, 19 and 22 min present the same local maximum 
pattern as DES.  The byproducts at 8 and 9 min also contain one local maximum in the 
corresponding absorbance spectrum; however, the maxima are located over 310 nm.  BPs at 8, 9, 
11, 13, 14 and 16 min eluted prior to DES when using a mobile phase of methanol and water and 
BPs at 19 and 22 min eluted after DES.  The absorbance spectra for DES and the observed 
ozonation byproducts are shown in Figure 3-56 and Figure 3-57. 
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Figure 3-56:  Absorbance of DES and Ozonation Byproducts in ESI Negative Mode 
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Figure 3-57:  Absorbance of DES and Ozonation Byproducts in ESI Positive Mode 
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Based on the retention times and corresponding polarity, mass spectra and absorbance at 240 nm, 
the major byproducts were identified for the ozonation of DES and presented in Table 3-10 and 
Table 3-11.   
 
Table 3-10:  Proposed Identification of DES and ESI Negative Ozonation Byproducts 
Analyte Retention Time (min) Identity 
DES 18 min Diethylstilbestrol 
Byproduct 1 8 min C18H20O3 MW 284 m/z 
Byproduct 2 9 min C18H19O4Cl MW 335 m/z 
Byproduct 3 11 min C18H20O3 MW 284 m/z 
Byproduct 4 12 min C18H20O3 MW 284 m/z 
Byproduct 5 13 min C18H20O3 MW 284 m/z 
Byproduct 6 14 min C18H20O3 MW 284 m/z 
Byproduct 7 16 min C18H20O4 MW 299 m/z 
Byproduct 8 19 min C18H19O4Cl MW 335 m/z 
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Table 3-11:  Proposed Identification of DES and ESI Positive Ozonation Byproducts 
Analyte Retention Time (min) Identity 
DES 18 min Diethylstilbestrol 
Byproduct 9 7 min MW 313 m/z 
Byproduct 10 8 min C18H19O4Cl MW 337 m/z 
Byproduct 11 9 min MW 353 m/z 
Byproduct 12 10 min C18H20O4 MW 300 m/z 
Byproduct 13 12 min C18H20O4 MW 300 m/z 
Byproduct 14 13 min C18H20O4 MW 300 m/z 
Byproduct 15 14 min MW 241 m/z 
Byproduct 16 15 min C18H20O4 MW 300 m/z 
Byproduct 17 17 min C18H20O4 MW 300 m/z 
Byproduct 18 19 min C18H19O4Cl MW 337 m/z 
Byproduct 19 21 min C18H19O4Cl MW 337 m/z 
 
Eight byproducts were formed during the ozonation of DES and detected in ESI negative mode.  
These byproduct formations were the result of oxygen radicals and molecular ozone attacking 
the phenolic moieties at the ortho position(s), with respect to the hydroxyl groups at C3 and C16.  
Based on the isotope pattern for byproducts 2, 8, 10, 18 and 19, chlorinated ozonation 
byproducts were produced from chlorine radicals which resulted from dilute levels of HCl (10-4 
M) in the ozone stock solution.  Byproducts 9, 11 and 15 were not identified due to the 
insufficient fragmentation information on the mass spectra. 
 
The mass spectra for DES and each ozonation byproduct formed are located in Appendix B.  The 
proposed reactions between ozone and DES are shown in Figure 3-58 and Figure 3-59, where 
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solid arrows indicate identified byproducts and dashed arrows signify potential byproducts.  The 
chlorinated DES ozonation byproducts are given in Figure 3-60. 
 
 
Figure 3-58:  Proposed ESI Negative Byproducts from Reaction of O3 and DES 
 
 
 
Figure 3-59:  Proposed ESI Positive Byproducts from Reaction of O3 and DES 
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A byproduct with the mass per charge of 285 m/z was found in the solvent front on the ESI 
positive spectra.  Since this was discovered in the solvent front, the byproduct could not be 
isolated in terms of molecular weight or quantified with respect to DES. 
 
 
Figure 3-60:  Proposed Chlorinated Ozonation Byproducts of DES 
 
Relative Quantification 
Since the ozone stock solution did not attain a highly concentrated solution, the short term 
ozonation dose volumes were relatively high compared to the other treatment dose volumes.  
This larger volume dose resulted in a dilution of the sample solutions and an artificial decrease in 
DES concentration for the short term reactions. 
 
The relative concentration of each ozonation byproduct was determined based on peak areas 
since authentic standards were unavailable for individual byproducts.  For purposes of relative 
concentrations, it was assumed that the only byproducts formed during the reactions were those 
that absorbed at a wavelength of 240 nm.  The estimated quantification of each byproduct was 
based on the initial concentration of DES (10.0 ± 1.0 µM) and the molecular weights found for 
each byproduct.  Figure 3-61 and Figure 3-62 provide DES and its ozonation (ESI negative and 
ESI positive) byproducts with respect to dose. 
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Figure 3-61:  Relative Concentrations of DES Short Term ESI Negative Ozonation Byproducts 
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Figure 3-62:  Relative Concentrations of DES Short Term ESI Positive Ozonation Byproducts 
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The instantaneous ozonation reactions showed a DES degradation of 35 % for 0.5 mg/L O3 
instantaneous dose.  For the short-term reactions with a dose of 6.0 mg/L O3, DES showed a 
percent degradation of 100 %.   
 
3.6 Comparison of Disinfectant Treatments 
Each treatment selected at least partially degraded the EDC contaminants; however, the efficacy 
of the treatment in reducing the parent compound showed a wide range with disinfection types.   
 
Free chlorine disinfection treatment demonstrated the highest degradation potential for both EE2 
and DES, as compared to chloramination and ozonation.  Both EE2 and DES have multiple 
potential reactions sites with chlorine due to the resonance capabilities of the phenolic moieties 
and their electron donating potentials.  The chlorination of EE2 resulted in nearly 100 % 
degradation for instantaneous, short term and long term reactions at the highest doses.  The same 
number and amount of byproducts were observed for all three contact times.  The DES and 
chlorine reaction showed 93 to 100 % degradation of the parent compound and a range of four to 
five byproduct formations directly correlating with the increased chlorine dose level. 
 
The chloramination of EE2 and DES provided the lowest degradation for both EE2 and DES 
because of the lack of basic chloramine reaction sites on the acidic estrogenic compounds.  The 
addition of ammonia after 30 sec of pre-chlorination effectively quenched the remaining free 
chlorine dose, which was also observed during the pre-ammoniation, simultaneous addition and 
pre-formed chloramines chloramination reactions.  The pre-chlorination chloramination of EE2 
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showed a lower percent degradation as compared to the chlorination reactions, as well as a 
decreased number and quantity of byproducts with only 27 to 62 % degradation and two 
byproduct formations.  These chloramination byproducts were identified as two of the three 
major byproducts associated with the chlorination of EE2; therefore, the predominant reaction 
during chloramination was chlorination of EE2.   
 
The pre-chlorination chloramination of DES displayed a significantly lower degradation 
percentage, 18 to 55 %, as compared to the chlorination of DES.  The instantaneous 
chloramination reactions did not produce any byproducts with the absorbance at 240 nm; 
however, the short term and long term reactions with DES produced two and three byproducts, 
respectively.  Since the number of byproducts increased with the chloramination dose and the 
pre-chlorination chloramination of DES garnered the highest byproduct formations, the 
chlorination reaction was the predominant reaction within the system.   
 
Because of the necessary dilution associated with each short term ozone dose, the percent 
degradation values were artificially lowered, thereby compromising the comparison of 
treatments.  Even with this caveat, the degradation of EE2 during the short term ozone reaction 
was 97 % at 60 mg min/L.  The degradation of DES was 100 % at 60 mg min/L O3, which was 
expected due to the double phenolic moiety providing increased reaction sites as compared to 
other estrogenic EDCs.  If the dose and parent degradation are compared, and the dilution is 
ignored, then ozonation of both EE2 and DES was more effective than chlorination and 
chloramination, even with the elongated reaction period.  In comparing the number of 
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byproducts formed with the ring structure still intact, ozonation of both EE2 and DES produced 
the highest byproduct formation potential out of the three selected disinfecting agents. 
 
The number of observable byproducts formed during ozonation was significantly higher than the 
number formed during chlorination and chloramination of EE2 and DES.  Since the ozonation 
reactions had the potential of forming both additional hydroxyl groups and carbonyl groups on 
the phenolic moieties, as well as a larger number of potential reaction sites, then an increased 
number of potential byproducts had the possibility of forming.  Following the other byproduct 
formations, it was assumed that as the dose increased, the byproduct formation potential would 
also increase.  This correlation was observed in the ozonation reaction with EE2, in that four 
byproducts were formed during instantaneous ozonation and sixteen were formed during short 
term ozonation.  With the ozonation of DES, however, the relationship between dose and number 
of byproducts remained constant.  The instantaneous and short term ozonation of DES both 
produced nineteen byproducts.  The increased number of reaction sites on DES accounts for the 
increased number of byproducts, as well as the same identity and number of byproducts formed 
during the both dose ratios.   
 
The chlorination of EE2 and DES produced the highest percent degradation of the parent 
compound, with the least number of byproducts.  Since the concentration of the byproducts can 
only be relative to the initial parent compound, the concentrations can only be estimated.  The 
molecular weights for each byproduct have been identified; therefore, the relative concentration 
of each byproduct can be obtained.  To determine the actual total concentrations for comparison, 
calibration curves of each byproduct would be required and then the sum of the total byproducts 
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could be determined.  Due to the lack of authentic standards, the total byproduct concentration 
can only be estimated with respect to the initial parent compound, which cannot exceed 10 µM. 
 
Table 3-12 and Table 3-13 present the byproduct comparison for EE2 and DES of treatment 
contact time and dose. 
 
Table 3-12: Byproduct Comparison for EE2 
Treatment Contact Time 
C·t* 
(mg min L-1) 
Percent 
Degradation 
of EE2# 
Number of 
Byproducts 
Produced 
Estimated 
Quantification 
of Total 
Byproducts 
Produced# 
Chlorination 
Instantaneous 
Short 
Long 
149 
1800 
17280 
100 % 
100 % 
100 % 
5 
5 
5 
10 µM 
10 µM  
10 µM 
Chloramination 
(Pre-Chlorination) 
Instantaneous 
Short 
Long 
149 
1800 
17280 
27 % 
52 % 
61.5 % 
2 
2 
2 
2.7 µM 
5.2 µM 
6.2 µM 
Ozonation Instantaneous Short 
0.5 
60 
23 % 
97 % 
4 
16 
2.3 µM 
9.7 µM 
*Instantaneous refers to 3600 sec reaction time, as reported in this table; Chloramination dose 
reported as Cl2 with Cl2:N of 4; Ozone reaction duration was assumed to be 10 min. 
#Based on ESI Negative peak areas and byproducts with ring structures intact. 
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Table 3-13: Byproduct Comparison for DES 
Treatment Contact Time 
C·t* 
(mg min L-1) 
Percent 
Degradation 
of DES# 
Number of 
Byproducts 
Produced 
Estimated 
Quantification 
of Total 
Byproducts 
Produced# 
Chlorination 
Instantaneous 
Short 
Long 
149 
1800 
17280 
93 % 
97 % 
100 % 
4 
4 
5 
9.3 µM 
9.7 µM 
10 µM 
Chloramination 
(Pre-Chlorination) 
Instantaneous 
Short 
Long 
149 
1800 
17280 
18 % 
37 % 
55 % 
0 
2 
3 
1.8 µM 
3.7 µM 
5.5 µM 
Ozonation Instantaneous Short 
0.5 
60 
35 % 
100 % 
19 
19 
3.5 µM 
10 µM 
*Instantaneous refers to 3600 sec reaction time, as reported in this table; Chloramination dose 
reported as Cl2 with Cl2:N of 4; Ozone reaction duration was assumed to be 10 min. 
#Based on ESI Negative peak areas and byproducts with ring structures intact. 
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4 Conclusions 
Emerging public health concerns relating to the epigenetic effects of EDCs, along with the 
reconceptualization of dose response curves, provides a compelling rationale for addressing 
estrogenically active contaminants in drinking water.  These environmental health concerns are 
now known to have long lasting impacts, especially on fetal development. 
 
For detection and quantification of EDCs, the optimized analytical method presented and 
implemented in this research was successfully used to determine the percent degradation of the 
parent compound for each disinfection treatment selected.  With the use of the molar absorption 
coefficients and the absorbance chromatograms, the optimized method decreased sample 
variability between injections.  The optimized method also provided a higher R2 in the linear 
calibration with both high and low concentrations.  Compared to the AquaAnalysis and EPA 
1694 methods, the optimized method also lowered the method quantification limits and the 
method detection limits.   
 
For this drinking water research, the estrogenic EDC byproducts were isolated and the treatment 
processes were compared using the dose applied, the number of byproducts formed and the 
relative quantification of the treatment byproducts.  Various contact time intervals, including 
instantaneous, short and long term contact, were used to compare the treatments.  The initial 
byproducts formed from the reactions were found with near instantaneous contact (on the order 
of seconds).  To simulate the contact time used in drinking water treatment plants, a short contact 
time was selected for each type of treatment process, excluding chloramination because this 
treatment is typically used as a secondary disinfectant.  Long contact times of 48 hours were 
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used to simulate the distribution system, with the exclusion of ozonation because this treatment 
is typically only used as a primary disinfectant.   
 
Each treatment process selected at least partially degraded the EDC contaminants.  The efficacy, 
however, of the respective treatments in reducing the parent compound showed a wide range of 
degradation by disinfection types.  Five chlorination byproducts of EE2 were observed with 
nearly 100 % degradation; only four byproducts, however, have been previously reported.  Two 
byproducts were isolated as a result of a chlorination reaction during the introduction of 
chloramines, when 61.5 % EE2 was degraded.  There were sixteen byproducts isolated from the 
ozonation of EE2 after 97 % degradation.  Previous ozonation studies have postulated the 
byproducts formed for the EE2 reactions; however, these hypothesized byproducts agree with 
those proposed identifications within this research.  For the DES reactions, there were five 
byproducts isolated for chlorination with nearly 100 % degradation and three byproducts isolated 
for chloramination, after 55 % degradation.  The ozonation of DES yielded nineteen byproducts, 
with nearly 100 % degradation of the parent compound.  Since there was no prior research or 
data available on the DES byproducts, proposed identification comparisons could not be made. 
 
From the resulting data, the chlorination of EE2 and DES produced the highest percent 
degradation of the parent compound, with the least number of byproducts for which the ring 
structures were still intact.  The chloramination of EE2 and DES provided the lowest degradation 
for both EE2 and DES because of the lack of basic chloramine reaction sites on the acidic 
estrogenic compounds.  The number of observable byproducts formed during ozonation was 
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significantly higher than the number formed during chlorination and chloramination of EE2 and 
DES.   
 
Proposed byproduct identifications utilized: the byproduct polarity relative to the parent 
compound; the molecular weight and fragmentation pattern obtained from the mass spectrum; 
the type of disinfection agent; the isotope pattern observed on the mass spectrum; and the 
absorbance of the byproduct at the local absorbance maximum of the parent compound.  The 
proposed byproduct structures for both the chlorination and chloramination treatments of EE2 
included intact and semi-intact ring structures with free chlorine substitution on the phenolic 
moiety and five-carbon ring.  The ozonation byproducts of EE2 appeared to retain the parent ring 
structure and aromatic-like absorbance characteristics, with hydroxyl and carbonyl group 
substitution on the phenolic moiety and the five-carbon ring.  The proposed byproducts for the 
chlorination and chloramination of DES maintained the parent ring structure with free chlorine 
substitution on both phenolic moieties.  The identifications proposed for the DES ozonation 
byproducts included hydroxyl and carbonyl substitutions on both phenolic moieties, while the 
phenolic rings remained intact. 
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5 Recommendations for Future Research 
Based on the observed data, there are amendments to the optimized method that could enhance 
byproduct detection capabilities.  Some byproducts could have been masked in the solvent front, 
providing a decreased number and quantity of byproducts produced from a given reaction.  The 
LC mobile phase method would need to be amended to provide a longer duration with a lower 
ratio of organic solvent to water, so that the more polar compounds would have increased 
retention on the stationary phase.  Another type of mobile or stationary phase could also be used 
to increase the retention times of compounds with high polarity, which may result in larger 
numbers of observable byproducts. 
 
Changes to the treatment methods could also establish a more stable basis for treatment 
comparisons.  The chlorination and chloramination reactions could be optimized for residual 
measurements at the shorter reaction times by using an in-line absorbance reaction cell.  Another 
method for producing ozone stock solution is needed so that the dose volume is lowered and the 
temperature is closer to the sample temperature.  These changes would decrease the method 
logically induced error discrepancies for the ozonation process as compared to the chlorination 
and chloramination processes. 
 
Further research on the link between absorbance and the estrogenic strength of individual 
byproducts is needed to strengthen the optimized method with verification that the phenolic 
moiety is the binding site with the estrogen receptor.  The use of nuclear magnetic resonance 
(NMR) spectroscopy of individual byproducts is necessary to verify each proposed byproduct 
structure, also confirming the intact ring structure for residual estrogenic behavior.  After 
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positive identification of each byproduct, calibration curves need to be prepared for accurate 
concentration determination and signal amplification through MRMs.   
 
Future research also needs to include other disinfection treatments (chlorine dioxide, UV 
irradiation, UV irradiation plus ozone, UV irradiation plus hydrogen peroxide, etc.) and other 
biologically active EDCs (natural estrogens, natural androgens, synthetic androgens, etc).  The 
synergistic effect of these compounds also needs research attention, so that interactions between 
the biologically active compounds can be studied along with individual treatment effects.  
Continuing research is needed to help in understanding the complete consequences of estrogenic 
endocrine disruptors in drinking water and the inevitable public health impact. 
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AquaAnalysis Methods 
Table A- 1:  AquaAnalysis SPE Loading Method 
Loading Method  
Solvent A: 100 % H2O 
Solvent B: 100 % MeOH (wash solvent) 
Time (min) Flow (mL/min) A% %B Curve 
Initial 5.00 100.0 0.0 Initial 
0.20 4.00 80.0 20.0 11 
4.00 1.00 100.0 0.0 11 
12.00 4.00 100.0 0.0 11 
 
Table A- 2:  AquaAnalysis SPE Elution Method 
Elution Method 
Solvent A: 2 % NH4OH in H2O 
Solvent B: 2 % NH4OH in ACN 
Time (min) Flow (mL/min) %A %B Curve 
Initial 0.40 70.0 30.0 Initial 
3.00 0.40 70.0 30.0 6 
12.50 0.40 35.0 65.0 6 
13.00 0.40 35.0 65.0 6 
14.00 0.40 70.0 30.0 6 
15.00 0.40 70.0 30.0 6 
 
Table A- 3:  AquaAnalysis SPE Flushing and Reconditioning Method 
Flushing and Reconditioning Method 
Solvent A: 100 % MeOH 
Solvent B: 20 % Acetone, 80% Ethyl Acetate 
Solvent C: 20 % Acetone, 80 % Pentane 
Time (min) Event Action 
Initial Set Flow A,B,C 0.10 
2.50 Set Flow A 4.00 
5.50 Set Flow B 2.00 
5.50 Set Flow C 2.00 
9.50 Set Flow C 0.10 
9.50 Set Flow B 0.10 
12.50 Set Flow A 0.10 
 
Table A- 4:  AquaAnalysis Autosampler Method 
Autosampler Method 
Repeat Injections 1 
Syringe Volume 5.0 mL 
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Table A- 5:  AquaAnalysis MS/MS Method Optimizations 
MS Method 
Ionization Mode ESI- 
Number of MRMs 5 pairs 
Time 0.00 to 15.00 min 
Inter-Channel Delay 0.02 
Inter-Scan Delay 0.02 
Repeats 1 
Span 0.1 
 
Table A- 6:  AquaAnalysis MRM Optimizations for Estrogenic EDCs 
Analyte Parent  
(m/z) 
Daughter  
(m/z) 
Dwell  
(sec) 
Cone  
(V) 
Collision  
Energy (eV) 
Estrone 269.3 145.3 0.2 50 30 
Estradiol 271.3 145.3 0.2 50 35 
Estriol 287.1 171.0 0.2 55 35 
17β-Ethinyl Estradiol 295.2 145.2 0.2 50 40 
Diethylstilbestrol 267.1 251.2 0.2 40 25 
 
Table A- 7:  AquaAnalysis MS Tune Parameters 
MS Tune 
ES-Source 
Capillary 3.50 kV 
Cone 45 V 
Exactor 3 V 
RF Lens 0.3 V 
Source Temp 140°C 
Desolvation Temp 350°C 
Desolvation Gas Flow 550 L/hr 
Cone Gas Flow 50 L/hr 
Analyser 
LM Resolution 1 13.0 
HM Resolution 1 13.0 
Ion Energy 1 0.4 
Entrance -2 
Collision 40 
Exit 0 
LM Resolution 2 13.0 
HM Resolution 2 13.0 
Ion Energy 2 0.8 
Multiplier 650 
API Gas UHP Nitrogen 
Collision Gas UHP Argon 
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Figure A- 1:  AquaAnalysis Low Concentration Curves 
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Figure A- 2:  AquaAnalysis High Concentration Curves 
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EPA 1694 Method  
Table A- 8:  EPA 1694 SPE Conditions 
SPE: Extraction and Concentration Conditions 
Solid Phase HLB Oasis® Cartridge 
Cartridge Conditioning 20 mL Methanol and 6 mL Water 
Sample Loading Rate 5-10 mL/min 
Extraction Volume 1 L 
Column Washing 10 mL Water 
Column Drying Time 5 min 
Column Elution 12 mL Methanol 
Blow-Down Gas UHP Nitrogen 
Water Bath Temperature 50 ± 5 °C 
Solvent Addition 3 mL Methanol 
Final Extract Volume 4.0 ± 0.1 mL with 0.1% Formic Acid Solution 
 
Table A- 9:  EPA 1694 General LC Conditions 
General LC Conditions 
Instrument Waters Alliance 2695 Separation Module with Waters Quattro microTM API Quadrupole Mass Spectrometer 
LC Column Waters C-18 Atlantis® T3, 3µm 2.1x50mm 
Ionization ESI- 
Acquisition MRM mode, unit resolution 
Injection Volume 15 µL 
Column Temperature 40 oC 
Flow Rate 0.200 mL/min 
Max Pressure 345 Bar 
Autosampler-Tray Temperature 4 oC 
LC Solvent 
Solvent A: 0.1 % Ammonium Acetate and 0.1 % Acetic 
Acid in HPLC water 
Solvent B: 1 to 1 Methanol to Acetonitrile 
 
Table A- 10:  EPA 1694 LC Gradient Program 
LC Gradient Program 
Time (min) Flow Mixture Gradient 
0.0 60 % Solvent A 40 % Solvent B 1 
0.5 60 % Solvent A 40 % Solvent B 6 
7.0 100 % Solvent B 6 
12.5 100 % Solvent B 6 
12.7 60 % Solvent A 40 % Solvent B 6 
16.0 60 % Solvent A 40 % Solvent B 1 
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Table A- 11:  EPA 1694 Method MS/MS Method Parameters 
MS Method 
Ionization Mode ESI- 
Number of MRMs 5 pairs 
Time 0.00 to 16.00 min 
Inter-Channel Delay 0.02 
Inter-Scan Delay 0.02 
Repeats 1 
Span 0.1 
 
Table A- 12:  EPA 1694 MRM Optimizations for Estrogenic EDCs 
Analyte Parent  
(m/z) 
Daughter  
(m/z) 
Dwell  
(sec) 
Cone  
(V) 
Collision  
Energy 
(eV) 
Estrone 269.3 145.3 0.2 50 30 
Estradiol 271.3 145.3 0.2 50 35 
Estriol 287.1 171.0 0.2 55 35 
17β-Ethinyl Estradiol 295.2 145.2 0.2 50 40 
Diethylstilbestrol 267.1 251.2 0.2 40 25 
 
Table A- 13:  EPA 1694 MS Conditions 
MS Conditions 
ES-Source 
Capillary 3.50 kV 
Cone 45 V 
Exactor 3 V 
RF Lens 0.3 V 
Source Temperature 100 oC 
Desolvation Temperature 350 oC 
Cone Gas Flow Rate 50 L/hr 
Desolvation Gas Flow Rate 300 L/hr 
Analyser 
LM Resolution 1 13.0 
HM Resolution 1 13.0 
Ion Energy 1 0.4 
Entrance -2 
Collision 40 
Exit 0 
LM Resolution 2 13.0 
HM Resolution 2 13.0 
Ion Energy 2 0.8 
Multiplier 650 
API Gas UHP Nitrogen 
Collision Gas UHP Argon 
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Figure A- 3:  EPA 1694 Method Low Concentration Curves 
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Figure A- 4:  EPA 1694 Method High Concentration Curves 
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Optimized Method  
Table A- 14:  Optimized Method LC and PDA Conditions 
General LC Conditions 
Instrument Waters Alliance 2695 Separation Module with Waters Quattro microTM API Quadrupole Mass Spectrometer 
LC Column Kromasil® C-18, 3.5µm 4.6x150mm 
Ionization ESI- 
Acquisition MRM mode, unit resolution 
Injection Volume 100 µL 
Column Temperature 40 oC 
Flow Rate 0.500 mL/min 
Max Pressure 345 Bar 
Autosampler-Tray Temperature 4 oC 
LC Solvent Solvent A: Water Solvent B: Methanol 
PDA Conditions 
Wavelength Range 210 to 400 nm 
Resolution 1.2 nm 
Sampling Rate 2 spectra/sec 
 
Table A- 15:  Optimized Method LC Gradient Program 
LC Gradient Program 
Time (min) Flow Mixture Gradient 
0.0 45 % Solvent A 55 % Solvent B 1 
1.00 45 % Solvent A 55 % Solvent B 1 
16.00 30 % Solvent A 70 % Solvent B 5 
21.00 30 % Solvent A 70 % Solvent B 1 
23.00 45 % Solvent A 55 % Solvent B 6 
 
Table A- 16:  Optimized Method MS/MS Method Parameters 
MS Method 
Ionization Mode ESI- 
Number of MRMs 5 pairs 
Time 0.00 to 23.00 min 
Inter-Channel Delay 0.02 
Inter-Scan Delay 0.02 
Repeats 1 
Span 0.1 
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Table A- 17:  Optimized Method MRM Parameters for Estrogenic EDCs 
Analyte Parent  
(m/z) 
Daughter  
(m/z) 
Dwell  
(sec) 
Cone  
(V) 
Collision  
Energy 
(eV) 
Estrone 269.3 145.3 0.2 50 30 
Estradiol 271.3 145.3 0.2 50 35 
Estriol 287.1 171.0 0.2 55 35 
17β-Ethinyl Estradiol 295.2 145.2 0.2 50 40 
Diethylstilbestrol 267.1 251.2 0.2 40 25 
 
Table A- 18:  Optimized Method MS Conditions 
MS Conditions 
ES-Source 
Capillary 3.50 kV 
Cone 45 V 
Exactor 3 V 
RF Lens 0.3 V 
Source Temperature 140 oC 
Desolvation Temperature 350 oC 
Cone Gas Flow Rate 50 L/hr 
Desolvation Gas Flow Rate 550 L/hr 
Analyser 
LM Resolution 1 13.0 
HM Resolution 1 13.0 
Ion Energy 1 0.4 
Entrance -2 
Collision 35 
Exit 0 
LM Resolution 2 13.0 
HM Resolution 2 13.0 
Ion Energy 2 0.8 
Multiplier 650 
API Gas UHP Nitrogen 
Collision Gas UHP Argon 
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Peak Areas = 2075.6039 [DES] + 48.910
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Figure A- 5:  Optimized Method Low Concentration Curves 
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Figure A- 6:  Optimized Method High Concentration Curves 
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Figure B-1:  Ethinylestradiol Mass Spectrum 
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Figure B-2:  Diethylstilbestrol Mass Spectrum
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EE2 and DES Chlorination Methods 
Initial ED concentrations of 10 ± 0.1 uM 
Total chlorine concentrations of ______ uM 
Temperature of solution 20 ºC 
 
Sample times 
0, 10, 20, 30, 40, 50, 60, 120, 300sec (5min), 600sec (10min), 1800sec (30min) 
 
1) Sample size of 150 mL of 10 ± 0.1 uM EE2 with a pH adjustment to ____ with 10 mM 
phosphoric acid buffer. 
  
2) Inject ______mL of chlorine solution for final concentration of 35 uM. (Cl solution should be 
approximately 1750 uM). Mix solution thoroughly.  
 
3) At time intervals of 0, 10, 20, 30, 40, 50, 60, 120, 300, 600sec, inject 100uL of sodium 
thiosulfate solution (100g/L) to quench the residual chlorine and stop the oxidation reaction. 
Measure pH after reaction. 
 
5) Samples analyzed using HPLC to determine the remaining ED concentration. 
 
After degradation has occurred, the byproducts will need to be identified to determine if the 
estrogenic activity has increased or decreased for the new daughter compounds.   
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Figure B-3:  Short Term Chlorination of EE2 Chromatogram 
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Figure B-4:  Instantaneous Chlorination of EE2 Chromatogram 
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Table B-1:  Instantaneous Chlorination of EE2 
 
% Total Peak Areas 
0 
sec 
10 
sec 
20 
sec 
30 
sec 
40 
sec 
50 
sec 
60 
sec 
120 
sec 
300 
sec 
600 
sec 
1800 
sec 
3600 
sec 
EE2 100 93.4 74.0 67.9 61.9 50.8 49.6 22.6 4.4 1.7 0.0 0.0 
Byproduct 1 
(11min) 0 3.9 11.6 11.9 17.3 15.8 18.8 16.5 8.3 1.6 0.0 0.0 
Byproduct 2 
(19min) 0 1.3 9.3 13.3 12.2 21.5 18.4 39.9 60.2 66.7 64.4 65.2 
Byproduct 3 
(15min) 0 0.0 0.6 1.1 0.7 2.2 1.6 3.2 4.3 5.8 28.0 28.4 
Byproduct 4 
(16min) 0 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.4 0.0 4.4 5.2 
Byproduct 5 
(13min) 0 1.4 4.5 5.8 7.8 9.8 11.2 17.1 22.4 24.2 3.2 1.2 
Other 
Byproducts 0 6.8 16.3 21.8 11.3 13.2 20.7 17.7 28.2 37.8 38.4 50.3 
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Figure B-5:  Instantaneous Chlorination of EE2 Percent Peak Areas 
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Table B-2:  Long and Short Term Chlorination of EE2 
 
Dose 
(mg/L) 
Cl2 Residual 
(mg/L) 
Standard 
Deviation Cl2 
Residual 
Concentration 
of EE2 (mg/L) 
Standard 
Deviation of 
EE2 
Short Term 
(5 hrs) 
1.5 0 0 0.104 0.038 
3.0 0.455 0.047 0.003 0.003 
6.0 2.585 0.031 0.001 0.001 
Long Term 
(48 hrs) 
1.5 0 0 0.132 0.042 
3.0 0 0 0.003 0.002 
6.0 0.125 0.038 NDL -- 
*NDL = non-detectable level 
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Figure B-6:  Chlorination Byproduct of EE2 
 
177 
 
m/z
100 200 300 400
In
te
n
sit
y
0.0
2.0e+5
4.0e+5
6.0e+5
8.0e+5
1.0e+6
1.2e+6
1.4e+6
1.6e+6
BP@14min 
363
312
 
Figure B-7:  Chlorination Byproduct of EE2 
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Figure B-8:  Chlorination Byproduct of EE2 
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Figure B-9:  Chlorination Byproduct of EE2 
 
m/z
100 200 300 400
In
te
n
sit
y
0
2e+5
4e+5
6e+5
8e+5
1e+6
1e+6
1e+6
2e+6
2e+6
2e+6
BP@19min 
379
343
 
Figure B-10:  Chlorination Byproduct of EE2 
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DES Chlorination 
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Figure B-11:  Instantaneous Chlorination of DES Chromatogram 
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Figure B-12:  Short Term Chlorination of DES Chromatogram 
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Table B-3:  Instantaneous Chlorination of DES 
 
% Total Peak Areas 
0 
sec 
10 
sec 
20 
sec 
30 
sec 
40 
sec 
50 
sec 
60 
sec 
120 
sec 
300 
sec 
600 
sec 
1800 
sec 
3600 
sec 
DES 97.8 96.4 91.5 87.0 83.6 78.9 78.5 58.8 30.3 13.1 2.4 0.6 
BP 1 
(13min) 0.0 0.0 0.0 0.0 1.3 2.0 2.6 7.5 20.0 31.2 29.5 24.6 
BP 2 
(14min) 2.2 2.1 2.1 1.9 1.7 2.6 2.4 2.2 2.0 1.1 0.4 0.0 
BP 3 
(15min) 0.0 0.0 0.0 0.1 0.1 1.3 1.6 2.3 5.1 7.4 5.9 5.2 
Other 
BPs 0.0 1.5 6.4 11.1 13.3 15.3 14.9 29.2 42.5 47.3 61.8 69.6 
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Figure B-13:  Instantaneous Chlorination of DES Percent Peak Area 
 
Table B-4:  Long and Short Term Chlorination of DES 
 
Dose 
(mg/L) 
Cl2 Residual 
(mg/L) 
Standard 
Deviation Cl2 
Residual 
Concentration 
of EE2 (mg/L) 
Standard 
Deviation of 
EE2 
Short Term 
(5 hrs) 
1.5 0 0 0.332 0.163 
3.0 0 0 0.022 0.002 
6.0 0 0 0 0.077 
Long Term 
(48 hrs) 
1.5 0 0 0.173 0.331 
3.0 0.018 0.013 0.003 0.007 
6.0 0.038 0.010 NDL -- 
*NDL = non-detectable level 
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Figure B-14:  Chlorination Byproduct of DES 
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Figure B-15:  Chlorination Byproduct of DES 
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Figure B-16:  Chlorination Byproduct of DES 
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Figure B-17:  Chlorination Byproduct of DES 
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Figure B-18:  Chlorination Byproduct of DES 
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Figure B-19:  Chlorination Byproduct of DES 
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EE2 and DES Chloramination Methods 
 
EE2  and DES Chloramination (Pre-Ammoniation) 
Initial ED concentration of 10 ± 0.1 uM 
Total chlorine concentration of ______ uM 
Total ammonia concentration of ______ uM 
Chlorine/Nitrogen Ratio of 4 mg-Cl2/mg-N 
Temperature of solution 20 ºC 
 
Sample times 
0, 30, 60, 120, 300sec (5min), 600sec (10min), 1800sec (30min), 3600sec (1hr) 
 
1) Sample size of 150 mL of 10 ± 0.1 uM EDC with a pH adjustment to 7.0 ± 0.5 with 10 mM 
phosphoric acid buffer. 
  
2) Inject ______mL of ammonia solution then ______mL of chlorine solution for final 
concentration of 35 uM and a Cl2/N of 4. Mix solution thoroughly.  
 
3) At time intervals of 0, 30, 60, 120, 300, 600, 1800, 3600sec, inject 100uL of sodium 
thiosulfate solution (100g/L) to quench the residual chloramines and stop the oxidation reaction. 
Measure pH after reaction. 
 
4) Samples analyzed using HPLC to determine the remaining ED concentration. 
 
 
EE2 and DES Chloramination (Simultaneous Addition) 
Initial ED concentration of 10 ± 0.1  uM 
Total chlorine concentration of ______ uM 
Total ammonia concentration of ______ uM 
Chlorine/Nitrogen Ratio of 4 mg-Cl2/mg-N 
Temperature of solution 20 ºC 
 
Sample times 
0, 30, 60, 120, 300sec (5min), 600sec (10min), 1800sec (30min), 3600sec (1hr) 
 
1) Sample size of 150 mL of 10 ± 0.1 uM EDC with a pH adjustment to 7.0 ± 0.5 with 10 mM 
phosphoric acid buffer. 
  
2) Inject ______mL of ammonia solution and ______mL of chlorine solution simultaneously for 
final concentration of 35 uM and a Cl2/N of 4. Mix solution thoroughly.  
 
3) At time intervals of 0, 30, 60, 120, 300, 600, 1800, 3600sec, inject 100uL of sodium 
thiosulfate solution (100g/L) to quench the residual chloramines and stop the oxidation reaction. 
Measure pH after reaction. 
 
4) Samples analyzed using HPLC to determine the remaining ED concentration. 
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EE2 and DES Chloramination (Pre-formed Chloramine Addition) 
Initial ED concentration of 10 ± 0.1 uM 
Total chlorine concentration of ______ uM 
Total ammonia concentration of ______ uM 
Chlorine/Nitrogen Ratio of 4 mg-Cl2/mg-N 
Temperature of solution 20 ºC 
 
Sample times 
0, 30, 60, 120, 300sec (5min), 600sec (10min), 1800sec (30min), 3600sec (1hr) 
 
1) Sample size of 150 mL of 10 ± 0.1 uM EDC with a pH adjustment to 7.0 ± 0.5 with 10 mM 
phosphoric acid buffer. 
 
2) Make ammonia solution (0.7175 M) so that the final volume will be 100 mL and Cl2/N of 4 
when chlorine stock solution (35 µM) is added slowly to NH2Cl solution. Stir for 10min. 
Measure residual.  Inject ______mL of chloramine solution.  
 
3) At time intervals of 0, 30, 60, 120, 300, 600, 1800, 3600sec, inject 100uL of sodium 
thiosulfate solution (100g/L) to quench the residual chloramines and stop the oxidation reaction. 
Measure pH after reaction. 
 
4) Samples analyzed using HPLC to determine the remaining ED concentration. 
 
 
EE2 and DES Chloramination (Pre-Chlorination Addition) 
Initial ED concentration of 10 ± 0.1 uM 
Total chlorine concentration of ______ uM 
Total ammonia concentration of ______ uM 
Chlorine/Nitrogen Ratio of 4 mg-Cl2/mg-N 
Temperature of solution 20 ºC 
 
Sample times 
0, 30, 60, 120, 300sec (5min), 600sec (10min), 1800sec (30min), 3600sec (1hr) 
 
1) Sample size of 150 mL of 10 ± 0.1 uM EDC with a pH adjustment to 7.0 ± 0.5 with 10 mM 
phosphoric acid buffer. 
 
2) Inject ______mL chlorine of solution, wait 30 sec, then ______mL of ammonia solution for 
final concentration of 35 uM and a Cl2/N of 4. Mix solution thoroughly.  
 
3) At time intervals of 0, 30, 60, 120, 300, 600, 1800, 3600sec, inject 100uL of sodium 
thiosulfate solution (100g/L) to quench the residual chloramines and stop the oxidation reaction. 
Measure pH after reaction. 
 
4) Samples analyzed using HPLC to determine the remaining ED concentration. 
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EE2 and DES Short and Long Chloramination (Pre-Chlorination Addition) 
Initial ED concentration of 10 ± 0.1 uM 
Total chlorine concentration of ______ uM 
Total ammonia concentration of ______ uM 
Chlorine/Nitrogen Ratio of 4 mg-Cl2/mg-N 
Temperature of solution 20 ºC 
 
Sample times 
5hrs, 48 hrs 
 
1) Sample size of 150 mL of 10 ± 0.1 uM EDC with a pH adjustment to 7.0 ± 0.5 with 10 mM 
phosphoric acid buffer. 
  
2) Inject ______mL chlorine of solution, wait 30 sec, then ______mL of ammonia solution for 
final concentration of 1.5, 3.0 and 6.0 mg/L Cl2 and a Cl2/N of 4. Mix solution thoroughly.  
 
3) After 5hrs and 48 hrs, measure free Cl2, Mono, and Dichloramines. Inject 100uL of sodium 
thiosulfate solution (100g/L) to quench the residual chloramines and stop the oxidation reaction. 
Measure pH after reaction. 
 
4) Samples analyzed using HPLC to determine the remaining ED concentration. 
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Table B-5:  Pre-Ammoniation Chloramination of EE2 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
EE2 96.8 92.1 91.4 91.1 90.1 87.1 89.4 89.4 
BP 1 (13min) 0 1.6 3.0 3.2 4.1 4.3 4.6 3.4 
Other BPs 3.2 6.3 5.6 5.7 5.8 8.6 6.0 7.2 
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Figure B-20:  Pre-Ammoniation Chloramination of EE2 Percent Peak Area 
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Figure B-21:  Pre-Ammoniation Chloramination of EE2 
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Table B-6:  Pre-Chlorination Chloramination of EE2 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
EE2 75.8 70.3 70.7 70.8 74.2 74.0 70.7 70.8 
BP 1 (13min) 9.1 14.9 16.0 16.1 14.1 15.7 16.1 15.7 
BP 2 (19min) 0 0.7 0.9 0.0 0.0 0.0 0.3 0.4 
Other BPs 15.1 14.1 12.4 13.0 11.7 10.3 12.9 13.1 
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Figure B-22:  Pre-Chlorination Chloramination of EE2 Percent Peak Area 
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Figure B-23:  Pre-Chlorination Chloramination of EE2 
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Table B-7:  Simultaneous Addition Chloramination of EE2 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
EE2 93.5 90.3 87.9 95.3 95.9 93.4 92.0 91.2 
BP 1 (13min) 0 3.0 3.9 4.4 2.7 2.2 3.8 3.8 
BP 2 (19min) 0.6 0.6 1.2 0.3 0.0 0.1 0.5 1.5 
Other BPs 5.9 6.0 7.0 0.0 1.4 4.3 3.8 3.4 
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Figure B-24:  Simultaneous Addition Chloramination of EE2 Percent Peak Area 
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Figure B-25:  Simultaneous Addition Chloramination of EE2 
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Table B-8:  Pre-Formed Chloramine Chloramination of EE2 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
EE2 98.6 99.4 98.6 98.9 98.2 98.3 94.0 98.4 
BP 1 (13min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 2 (19min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Other BPs 1.4 0.6 1.4 1.1 1.8 1.7 6.0 1.6 
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Figure B-26:  Pre-Formed Chloramine Chloramination of EE2 
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Figure B-27:  Pre-Formed Chloramine Chloramination of EE2 
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Table B-9:  Chloramination Residuals with Standard Deviations of EE2 Reactions 
 
Dose as 
Cl2 
(C:N of 4) 
Cl2 
Residual 
(mg/L) 
NH2Cl 
Residual 
(mg/L) 
NHCl2 
Residual 
(mg/L) 
Concentration 
of EE2  
(mg/L) 
Pre-Ammoniation 
(3600 sec) 35 µM 0.00 ± 0 2.34 ± 0.02 0.04 ± 0.02 6.98 ± 0.15 
Pre-Chlorination 
(3600 sec) 35 µM 0.00 ± 0 2.34 ± 0.08 0.00 ± 0 5.47 ±0.13 
Simultaneous 
Addition 
(3600 sec) 
35 µM 0.05 ± 0.05 2.36 ± 0.05 0.20 ± 0.23 5.86 ± 0.08 
Pre-Mixed 
Chloramination  
(3600 sec) 
35 µM 0.00 ± 0 1.78 ± 0.07 0.06 ± 0.01 7.20 ±0.11 
Short Term 
Pre-Chlorination 
1.5 mg/L 0.00 ± 0 1.26 ±0.05 0.00 ± 0 5.78 ± 0.03 
3.0 mg/L 0.00 ± 0 2.33 ± 0.21 0.28 ± 0.50 4.64 ± 0.16 
6.0 mg/L 0.07 ± 0.04 5.11 ± 0.15 0.02 ± 0.05 3.41 ± 0.03 
Long Term 
Pre-Chlorination 
1.5 mg/L 0.00 ± 0 1.05 ± 0.03 0.01 ± 0.01 5.32 ± 0.03 
3.0 mg/L 0.00 ± 0 2.35 ± 0.43 0.05 ± 0.05 3.65 ± 0.33 
6.0 mg/L 0.00 ± 0 4.15 ± 0.13 0.07 ± 0.06 2.70 ± 0.04 
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Figure B-28:  Chloramination Byproduct of EE2 
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Figure B-29:  Chloramination Byproduct of EE2 
193 
 
Table B-10:  Pre-Ammoniation Chloramination of DES 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
DES 99.5 98.2 96.2 94.7 95.9 94.4 94.9 93.3 
BP 1 (13min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 2 (15min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 3 (17min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Other BPs 0.5 1.8 3.8 5.3 4.1 5.6 5.1 6.7 
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Figure B-30:  Pre-Ammoniation Chloramination of DES Percent Peak Area 
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Figure B-31:  Pre-Ammoniation Chloramination of DES 
194 
 
Table B-11:  Pre-Chlorination Chloramination of DES 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
DES 87.7 82.2 82.5 84.4 84.3 83.1 82.6 83.5 
BP 1 (13min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 2 (15min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 3 (17min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Other BPs 12.3 17.8 17.5 15.6 15.7 16.9 17.4 16.5 
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Figure B-32:  Pre-Chlorination Chloramination of DES Percent Peak Area 
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Figure B-33:  Pre-Chlorination Chloramination of DES 
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Table B-12:  Simultaneous Addition Chloramination of DES 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
DES 94.6 93.9 95.2 94.8 92.8 94.9 93.5 92.2 
BP 1 (13min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 2 (15min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 3 (17min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Other BPs 5.4 6.1 4.8 5.2 7.2 5.1 6.5 7.8 
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Figure B-34:  Simultaneous Addition Chloramination of DES Percent Peak Area 
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Figure B-35:  Simultaneous Addition Chloramination of DES 
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Table B-13:  Pre-Formed Chloramine Chloramination of DES 
 
% Total Peak Areas 
0 sec 30 sec 60 sec 120 sec 300 sec 600 sec 1800 sec 3600 sec 
DES 97.0 93.8 94.0 97.8 100.0 98.3 100.1 99.2 
BP 1 (13min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 2 (15min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
BP 3 (17min) 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Other BPs 3.0 6.2 6.0 2.2 0.0 1.7 -0.1 0.8 
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Figure B-36:  Pre-Formed Chloramine Chloramination of DES Percent Peak Area 
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Figure B-37:  Pre-Formed Chloramine Chloramination of DES 
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Table B-14:  Chloramination Residuals with Standard Deviations of DES Reactions 
 
Dose as Cl2 
(C:N of 4) 
Cl2 
Residual 
(mg/L) 
NH2Cl 
Residual 
(mg/L) 
NHCl2 
Residual 
(mg/L) 
Concentration of 
DES (mg/L) 
Pre-Ammoniation 
(3600 sec) 35 µM 0.00 ± 0 1.98 ± 0.57 0.09 ± 0.03 26.32 ± 0.81 
Pre-Chlorination 
(3600 sec) 35 µM 0.00 ± 0 2.43 ± 0.04 0.00 ± 0 27.07 ± 0.52 
Simultaneous 
Addition  
(3600 sec) 
35 µM 0.01 ± 0.01 2.33 ± 0.19 0.05 ± 0.02 28.84 ± 0.42 
Pre-Mixed 
Chloramination  
(3600 sec) 
35 µM 0.00 ± 0 1.69 ±0.11 0.08 ± 0.02 32.57 ± 2.17 
Short Term  
Pre-Chlorination 
1.5 mg/L 0.00 ± 0 1.27 ± 0.03 0.01 ± 0.01 28.54 ± 0.05 
3.0 mg/L 0.00 ± 0 2.60 ± 0.05 0.03 ± 0.01 25.68 ± 0.12 
6.0 mg/L 0.03 ± 0.02 5.46 ± 0.10 0.03 ± 0.06 19.45 ± 0.20 
Long Term  
Pre-Chlorination 
1.5 mg/L 0.00 ± 0 1.04 ± 0.02 0.01 ± 0.02 34.53 ± 0.44 
3.0 mg/L 0.00 ± 0 2.22 ± 0.04 0.00 ± 0 28.93 ± 0.58 
6.0 mg/L 0.00 ± 0 4.02 ± 0.08 0.04 ± 0.04 19.60 ± 0.35 
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Figure B-38:  Chloramination Byproducts of DES 
198 
 
m/z
100 200 300 400
In
te
n
sit
y
0
1e+5
2e+5
3e+5
4e+5
5e+5
6e+5
BP@15min 
301
218
232175145
 
Figure B-39:  Chloramination Byproducts of DES 
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Figure B-40:  Chloramination Byproducts of DES 
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Ozone Treatment of EDCs 
 
EDC Instantaneous Ozonation 
Initial ED concentration of 10 ± 0.1 uM 
Temperature of solution 20 ºC 
 
Ozone Doses 
1, 2, 4, 6, 8, 10 uM 
 
1) Sample size of 50 mL of 10 ± 0.1 uM EDC with a pH adjustment to 7.0 ± 0.5 with 10 mM 
phosphoric acid buffer. 
  
2) Bubble oxygen through 10-4M HCl solution to produce O3.  Measure concentration at 258 nm 
to determine dose amounts (ε258 nm = 3000 M-1cm-1). 
 
3) Inject ozone solution for final concentrations of 1, 2, 4, 6, 8, 10 uM. Mix solution thoroughly. 
Allow reaction to run to completion. 
 
4) Measure pH after reaction. Measure O3 absorbance after dosing. 
 
5) Samples analyzed using HPLC to determine the remaining ED concentration. 
 
 
EE2 Short Term Ozonation 
Initial ED concentration of 10 ± 0.1 uM 
Temperature of solution 20 ºC 
 
Ozone Doses 
1.5, 2.0, 3.0, 6.0 mg/L 
 
1) Sample size of 50 mL of 10 ± 0.1 uM EE2 with a pH adjustment to 7.0 ± 0.5  with 10 mM 
phosphoric acid buffer. 
  
2) Bubble oxygen through 10-4M HCl solution to produce O3.  Measure concentration at 258 nm 
to determine dose amounts (ε258 nm = 3000 M-1cm-1). 
 
3) Inject ozone solution for final concentrations of 1.5, 2.0, 3.0, 6.0 mg/L. Mix solution 
thoroughly. Allow reaction to run to completion. 
 
4) Measure pH after reaction. Measure O3 absorbance after dosing. 
 
5) Samples analyzed using HPLC to determine the remaining ED concentration. 
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Table B-15:  Instantaneous Ozonation of EE2 (ESI Negative) 
 
% Total Peak Areas 
1 uM 2 uM 4 uM 6 uM 8 uM 10 uM 
EE2 97.9 96.4 89.7 85.7 80.5 76.6 
Byproduct 1 (9min) 0.0 0.0 0.0 0.0 0.0 0.0 
Byproduct 2 (11min) 0.0 0.2 0.9 1.2 1.6 2.0 
Byproduct 3 (13min) 0.0 0.7 1.4 3.5 5.0 6.6 
Byproduct 4 (15min) 0.0 0.0 0.0 0.0 0.0 0.0 
Byproduct 5 (19min) 0.0 0.0 0.0 0.0 0.0 0.0 
Other BPs 2.1 2.7 8.0 9.6 13.0 14.8 
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Figure B-41:  Ozonation of EE2 Percent Peak Area (ESI Negative) 
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Table B-16:  Instantaneous Ozonation of EE2 (ESI Positive) 
 
% Total Peak Areas 
1 uM 2 uM 4 uM 6 uM 8 uM 10 uM 
EE2 90.6 86.9 84.7 78.1 75.1 67.7 
Byproduct 9 (10min) 0.0 0.0 0.9 1.3 1.9 2.4 
Byproduct 14 (16min) 0.0 0.0 0.0 0.0 0.4 0.5 
Other Byproducts 9.4 13.1 14.4 20.6 22.6 29.4 
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Figure B-42:  Ozonation of EE2 Percent Peak Area (ESI Positive) 
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Table B-17:  Short Term Ozonation of EE2 (ESI Negative) 
 
% Total Peak Areas 
1.5 mg/L 2.0 mg/L 3.0 mg/L 6.0 mg/L 
EE2 56.3 43.4 26.4 2.5 
Byproduct 1 (9min) 0.6 0.9 1.5 3.3 
Byproduct 2 (11min) 6.4 8.8 12.3 19.9 
Byproduct 3 (13min) 8.5 14.2 14.7 8.1 
Byproduct 4 (15min) 0.0 0.0 0.0 1.4 
Byproduct 5 (19min) 0.5 1.3 3.1 13.4 
Other Byproducts 27.7 31.3 42.0 51.5 
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Figure B-43:  Short Term Ozonation of EE2 Percent Peak Area (ESI Negative) 
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Table B-18:  Short Term Ozonation of EE2 (ESI Positive) 
 
% Total Peak Areas 
1.5 mg/L 2.0 mg/L 3.0 mg/L 6.0 mg/L 
EE2 42.4 32.9 16.1 0.0 
Byproduct 6 (7min) 0.6 0.5 0.6 0.4 
Byproduct 7 (8min) 0.5 0.3 0.1 0.4 
Byproduct 8 (9min) 1.2 1.3 5.6 2.0 
Byproduct 9 (10min) 8.1 8.7 14.0 21.1 
Byproduct 10 (12min) 6.2 6.0 4.9 2.8 
Byproduct 11 (13min) 0.0 0.2 0.3 0.6 
Byproduct 12 (14min) 0.0 0.0 0.0 0.2 
Byproduct 13 (15min) 0.7 0.4 0.4 0.7 
Byproduct 14 (16min) 1.6 1.7 2.1 1.4 
Byproduct 15 (17min) 0.5 0.3 0.4 0.7 
Byproduct 16 (19min) 0.9 1.7 4.9 10.3 
Other Byproducts 37.4 46.0 50.5 59.3 
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Figure B-44:  Short Term Ozonation of EE2 Percent Peak Area (ESI Positive) 
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Figure B-45:  Ozonation Byproducts of EE2 (ESI Negative) 
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Figure B-46:  Ozonation Byproducts of EE2 (ESI Negative) 
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Figure B-47:  Ozonation Byproducts of EE2 (ESI Negative) 
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Figure B-48:  Ozonation Byproducts of EE2 (ESI Negative) 
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Figure B-49:  Ozonation Byproducts of EE2 (ESI Negative) 
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Figure B-50:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-51:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-52:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-53:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-54:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-55:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-56:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-57:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-58:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-59:  Ozonation Byproducts of EE2 (ESI Positive) 
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Figure B-60:  Ozonation Byproducts of EE2 (ESI Positive) 
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Table B-19:  Instantaneous Ozonation of DES (ESI Negative) 
 
% Total Peak Areas 
1uM 2uM 4uM 6uM 8uM 10uM 
DES 98.5 95.3 91.3 77.8 67.9 64.9 
Byproduct 1 (8min) 0.1 0.1 0.1 0.3 0.4 0.4 
Byproduct 2 (9min) 0.3 0.3 0.3 0.7 1.0 1.1 
Byproduct 3 (11min) 0.2 0.2 0.2 0.4 0.3 0.3 
Byproduct 4 (12min) 0.0 0.1 0.1 0.2 0.2 0.2 
Byproduct 5 (13min) 0.1 0.1 0.1 0.2 0.2 0.3 
Byproduct 6 (14min) 0.7 0.7 0.7 1.2 1.2 1.1 
Byproduct 7 (21min) 0.2 0.1 0.1 0.0 0.1 0.1 
Other Byproducts 0.0 3.2 7.1 19.3 28.7 31.6 
 
Ozone Dose
1uM 2uM 4uM 6uM 8uM 10uM
Pe
rc
en
t P
ea
k 
A
re
a
0
20
40
60
80
100
DES 
BP@8min 
BP@9min 
BP@11min 
BP@12min 
BP@13min 
BP@14min 
BP@21min 
Other BPs 
  
Figure B-61:  Percent Peak Area for Ozonation Byproducts of DES (ESI Negative) 
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Table B-20:  Instantaneous Ozonation of DES (ESI Positive) 
 
% Total Peak Areas 
1uM 2uM 4uM 6uM 8uM 10uM 
DES 93.0 93.5 92.6 83.3 82.8 62.8 
Byproduct 1 (7min) 1.4 1.1 1.8 1.5 1.8 1.2 
Byproduct 2 (8min) 0.6 0.7 0.4 0.6 0.7 0.9 
Byproduct 3 (9min) 1.1 1.1 1.1 1.1 1.1 1.0 
Byproduct 4 (10min) 0.1 0.1 0.2 0.2 0.2 0.5 
Byproduct 5 (12min) 0.6 0.5 0.5 0.7 0.7 0.6 
Byproduct 6 (13min) 0.2 0.2 0.2 0.4 0.4 0.4 
Byproduct 7 (14min) 2.1 2.1 2.3 2.1 1.8 2.0 
Byproduct 8 (16min) 0.3 0.1 0.3 2.3 3.8 0.2 
Byproduct 9 (21min) 0.8 0.7 0.6 0.6 0.4 0.2 
Other Byproducts 0.0 0.0 0.0 7.2 6.3 30.1 
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Figure B-62:  Percent Peak Area for Ozonation Byproducts of DES (ESI Positive) 
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Table B-21:  Short Term Ozonation of DES (ESI Negative) 
 
% Total Peak Areas 
1.5mg/L 2.0mg/L 3.0mg/L 6mg/L 
DES 16.8 5.9 0.9 0.0 
Byproduct 1 (8min) 0.3 0.5 0.5 0.2 
Byproduct 2 (9min) 4.5 8.7 9.3 1.6 
Byproduct 3 (11min) 0.3 0.3 0.2 0.0 
Byproduct 4 (12min) 0.3 0.4 0.6 0.4 
Byproduct 5 (13min) 0.2 0.3 0.2 0.0 
Byproduct 6 (14min) 0.3 0.5 0.4 0.0 
Byproduct 7 (16min) 5.6 5.6 0.0 0.0 
Byproduct 8 (19min) 0.9 0.7 0.0 0.0 
Other Byproducts 70.7 77.2 87.8 97.7 
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Figure B-63:  Percent Peak Area for Short Term Ozonation Byproducts of DES (ESI Negative) 
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Table B-22:  Short Term Ozonation of DES (ESI Positive) 
 
% Total Peak Areas 
1.5mg/L 2.0mg/L 3.0mg/L 6mg/L 
DES 13.1 3.9 0.6 0.0 
Byproduct 9 (7min) 1.1 1.5 1.0 1.2 
Byproduct 10 (8min) 0.9 0.4 0.5 0.3 
Byproduct 11 (9min) 3.2 5.5 7.9 2.0 
Byproduct 12 (10min) 0.3 0.2 0.3 0.2 
Byproduct 13 (12min) 0.3 0.5 0.6 0.6 
Byproduct 14 (13min) 0.3 0.3 0.3 0.0 
Byproduct 15 (14min) 0.9 0.9 0.6 0.0 
Byproduct 16 (15min) 5.0 6.6 5.4 1.7 
Byproduct 17 (17min) 5.4 0.6 0.2 0.0 
Byproduct 18 (19min) 0.5 0.3 0.1 0.0 
Byproduct 19 (21min) 0.3 0.3 0.2 0.0 
Other Byproducts 68.7 78.9 82.3 94.1 
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Figure B-64:  Percent Peak Area for Short Term Ozonation Byproducts of DES (ESI Positive) 
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Figure B-65:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-66:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-67:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-68:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-69:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-70:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-71:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-72:  Ozonation Byproduct of DES (ESI Negative) 
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Figure B-73:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-74:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-75:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-76:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-77:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-78:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-79:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-80:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-81:  Ozonation Byproduct of DES (ESI Positive) 
 
 
m/z
100 200 300 400
In
te
n
sit
y
0
2e+5
4e+5
6e+5
8e+5
1e+6
BP18@19min 
337
301
255
  
Figure B-82:  Ozonation Byproduct of DES (ESI Positive) 
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Figure B-83:  Ozonation Byproduct of DES (ESI Positive) 
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